Inside BCIBrain-Computer Interface industry news, research breakthroughs, and market analysis.https://insidebci.com/en-usA decade in Nathan Copeland's brain: the Pitt ICMS safety paper landshttps://insidebci.com/news/2026-07-18-pitt-uchicago-icms-decade-safety-copeland-science-translational-medicine/https://insidebci.com/news/2026-07-18-pitt-uchicago-icms-decade-safety-copeland-science-translational-medicine/On 15 July 2026, Science Translational Medicine published a five-participant, ten-year safety study of intracortical microstimulation in the somatosensory cortex. The Pitt and University of Chicago team led by Robert Gaunt and Charles Greenspon delivered 168 million pulses across 27 combined years of implant time with no serious adverse events. The longest single participant is with very high confidence Nathan Copeland, first implanted on Star Wars Day 2015, still living publicly with the same Utah arrays eleven years later.Sat, 18 Jul 2026 00:00:00 GMTnewsnewsICMSintracortical-microstimulationsomatosensory-cortexNathan-CopelandRobert-GauntCharles-GreensponPittUniversity-of-ChicagoUPMCBlackrock-Utah-arrayScience-Translational-Medicinelong-term-safetySliman-Bensmaiasensory-restorationspinal-cord-injuryKeith Thomas can feel his dog: Feinstein's three-year double neural bypass lands in Nature Medicinehttps://insidebci.com/news/2026-07-18-feinstein-double-neural-bypass-keith-thomas-nature-medicine/https://insidebci.com/news/2026-07-18-feinstein-double-neural-bypass-keith-thomas-nature-medicine/On 16 July 2026, Nature Medicine put on its cover a three-year follow-up of Keith Thomas of Massapequa, New York, who was implanted with five microelectrode arrays in March 2023 as the first participant in the Feinstein Institutes' 'double neural bypass' trial. The Chad Bouton team's paper reports that Thomas can now feed himself, drink from a cup, feel touch on his right wrist, and pet his dog Bow, with strength and sensation gains persisting more than two years after the stimulation was switched off.Sat, 18 Jul 2026 00:00:00 GMTnewsnewsFeinstein-InstitutesNorthwell-HealthChad-BoutonKeith-ThomasNature-Medicinedouble-neural-bypasshybrid-neuroprosthesistetraplegiacervical-spinal-cord-injurytranscutaneous-spinal-cord-stimulationcortical-mirroringsomatosensory-cortexneuroplasticityBattelle-NeuroLifeIan-BurkhartBrainCo unveils a brain-to-robot developer platform at WAIC 2026 in Shanghaihttps://insidebci.com/market/2026-07-18-brainco-waic-2026-brain-to-robot-platform-nyx-he/https://insidebci.com/market/2026-07-18-brainco-waic-2026-brain-to-robot-platform-nyx-he/On Friday 17 July 2026, at the World Artificial Intelligence Conference in Shanghai, BrainCo debuted its Brain-Controlled Robot AI Platform, a graphical developer toolkit that pairs its non-invasive EEG headset with third-party humanoid, robotic-arm, and quadruped robots from Unitree, Realman, and Deep Robotics. Nyx He, partner and senior vice president, framed the launch as the next chapter of human-machine collaboration. Live demonstrations at the booth showed a person in an EEG headband directing a robotic arm to pick up a cup and an apple without buttons, voice, or muscle movement.Sat, 18 Jul 2026 00:00:00 GMTmarketmarketBrainCoWAIC-2026Shanghaibrain-controlled-robotEEGNeuro-Embodied-AINyx-HeHan-BichengHangzhou-Six-Little-DragonsBrainRoboticsHKEX-IPOIndustrial-Builder-postureChina performs first commercial Neuracle NEO implanthttps://insidebci.com/news/2026-07-16-neuracle-neo-shanghai-huashan-first-commercial-invasive-bci-motor-restoration/https://insidebci.com/news/2026-07-16-neuracle-neo-shanghai-huashan-first-commercial-invasive-bci-motor-restoration/On Monday 13 July 2026, neurosurgeons at Huashan Hospital affiliated with Fudan University performed the first commercial implantation of Neuracle's NEO brain-computer interface in a male patient with tetraplegia from a decade-old cervical spinal cord injury. The device is coin-sized, epidural, battery-free, and drives a pneumatic glove for hand grasping. Neuracle NEO is the world's first commercial invasive brain-computer interface implant for motor restoration in paralysis, following NMPA Class III market approval on 13 March 2026.Thu, 16 Jul 2026 00:00:00 GMTnewsnewsNeuracleNEOBoruikangShanghai-Huashan-HospitalFudan-Universitycommercial-invasive-BCIcervical-spinal-cord-injurytetraplegiaChinaNMPASTAR-Market-IPOTsinghua-UniversityXu-HonglaiHuang-XiaoshanMao-YingWu-ZehanIndustrial-Builder-postureThe BCI category is broadening beyond motor restoration in 2026https://insidebci.com/market/2026-07-13-bci-vertical-broadening-beyond-motor-2026-synthesis/https://insidebci.com/market/2026-07-13-bci-vertical-broadening-beyond-motor-2026-synthesis/Across the first half of 2026 and the first weeks of the second half, three US Food and Drug Administration Breakthrough Device Designations were granted to non-motor-indication BCI and neuromodulation devices, Cortigent's existing Breakthrough-designated visual cortical prosthesis programme disclosed a secondary stroke motor rehab arm, three first-in-human or investigational-device clinical milestones landed, and two significant peer-reviewed publications extended the field's clinical use case. The motor-restoration pipeline itself continued to expand in the same window. This is a synthesis piece on what the data pattern actually shows and does not show.Mon, 13 Jul 2026 00:00:00 GMTmarketmarketsynthesisFDA-Breakthrough-Device-DesignationNia-TherapeuticsAurenarReVision-ImplantCortigent-OrionNeuronoffCoherence-NeuroMotif-NeurotechRush-ICVPBath-UlsterChalmers-ValleCorTecNeuralinkParadromicsPrecision-NeuroscienceOnward-MedicalABILITY-NeurotechEpia-NeuroBeijing Tiantan Hospital seeds Xizang's first plateau BCI centre at Lhasa People's Hospitalhttps://insidebci.com/policy/2026-07-10-xizang-lhasa-plateau-bci-clinical-center-tiantan/https://insidebci.com/policy/2026-07-10-xizang-lhasa-plateau-bci-clinical-center-tiantan/Xinhua reported on 9 July 2026 that Xizang (Tibet Autonomous Region)'s first plateau brain-computer interface clinical application centre was inaugurated at Lhasa People's Hospital. A medical assistance team from Beijing Tiantan Hospital, Capital Medical University, introduced the non-invasive EEG-based BCI technology, which drives exoskeleton and robotic-arm actuators for motor rehabilitation. The centre sits within a six-year Tiantan-Lhasa department-support partnership dating to 2020, and targets cerebral haemorrhage, cerebral ischemia, TBI, spinal cord injury, and peripheral nerve injury indications.Fri, 10 Jul 2026 00:00:00 GMTpolicypolicyChinaXizangTibetLhasaplateau-BCIBeijing-Tiantan-HospitalLhasa-Peoples-Hospitalnon-invasive-BCIEEGexoskeletonmedical-aid-TibetBai-YouqingIndustrial-Builder-postureCNBC profiles BrainCo as the Hangzhou non-invasive BCI leader runs up to its Hong Kong IPOhttps://insidebci.com/market/2026-07-10-cnbc-brainco-nyx-he-hangzhou-hk-ipo-run-up/https://insidebci.com/market/2026-07-10-cnbc-brainco-nyx-he-hangzhou-hk-ipo-run-up/CNBC published a video interview by China reporter Elaine Yu with Nyx He, Partner and Senior Vice President at BrainCo, on 10 July 2026. The interview lands six months after BrainCo confidentially filed for a Hong Kong Stock Exchange listing on 12 January 2026 with CICC and UBS Group AG as arrangers, and six months after the company closed a ¥2 billion (approximately US$286 million) financing round co-led by IDG Capital and Walden International on 8 January 2026. BrainCo is one of Hangzhou's Six Little Dragons alongside DeepSeek, Unitree Robotics, Game Science, DEEP Robotics, and Manycore Tech.Fri, 10 Jul 2026 00:00:00 GMTmarketmarketBrainCoNyx-HeHan-BichengCNBCElaine-YuHong-Kong-IPOHangzhou-Six-Little-Dragonsnon-invasive-BCIBrainRoboticsIDG-CapitalWalden-InternationalIndustrial-Builder-postureChinaParadromics hires Verily's former head of clinical neurology as Chief Clinical Officerhttps://insidebci.com/market/2026-07-07-paradromics-william-marks-chief-clinical-officer-verily/https://insidebci.com/market/2026-07-07-paradromics-william-marks-chief-clinical-officer-verily/Paradromics announced on 7 July 2026 that William J. Marks, Jr., MD, MS-HCM, has joined as Chief Clinical Officer, a role distinct from the Chief Medical Officer position held by neurosurgeon Stephen Ryu. Marks was Head of Clinical Neurology and Head of Clinical Science at Verily Life Sciences from 2016 to 2023, before co-founding Nexus NeuroTech Ventures, which wound down 31 March 2026. The hire lands three weeks after Paradromics' first-in-human Connexus BCI implant at University of Michigan Health on 17 June 2026.Tue, 07 Jul 2026 00:00:00 GMTmarketmarketParadromicsWilliam-MarksChief-Clinical-OfficerVerily-Life-SciencesAlphabetNexus-NeuroTech-VenturesStephen-RyuMatt-AngleConnexusConnect-Oneclinical-trialUniversity-of-Michigan-HealthBeijing names Changfazhan its first BCI incubation platform under the Future Industry programmehttps://insidebci.com/policy/2026-07-07-beijing-changfazhan-bci-incubation-platform-changping-shanghai-financing/https://insidebci.com/policy/2026-07-07-beijing-changfazhan-bci-incubation-platform-changping-shanghai-financing/Beijing Municipal Bureau of Economy and Information Technology announced on 1 July 2026, with English release on 7 July, that the Changfazhan Brain Science and Brain-Computer Interface Incubation Platform in Changping district has been designated as one of seven newly recognised Future Industry Incubation Platforms, the first BCI-specific platform under that specific programme. Shanghai municipal science commission director Luo Dajin separately claimed on 6 July that Shanghai hosted nearly 60 per cent of China's BCI financing events, 40 per cent of the disclosed funding amount, and one-third of the country's BCI companies in the first half of 2026.Tue, 07 Jul 2026 00:00:00 GMTpolicypolicyChinaBeijingChangpingChangfazhanFuture-Industry-Incubation-Platform育新平台ZhongguancunShanghaiLuo-DajinSTCSMIndustrial-Builder-postureChina-BCI-financing-H1-2026Nia Therapeutics gets FDA Breakthrough Designation for a preclinical TBI memory implanthttps://insidebci.com/market/2026-07-05-nia-therapeutics-sns-fda-breakthrough-tbi-memory-implant/https://insidebci.com/market/2026-07-05-nia-therapeutics-sns-fda-breakthrough-tbi-memory-implant/Nia Therapeutics, an Allston Massachusetts company co-founded in 2018 by University of Pennsylvania memory neuroscientist Michael Kahana and cognitive neuromodulation researcher Daniel Rizzuto, received FDA Breakthrough Device Designation on 13 March 2026 for its Smart Neurostimulation System (SNS), indicated for episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The SNS is a 60-channel wireless closed-loop cortical implant whose platform hardware was validated in a sheep study published in Brain Stimulation in December 2025. It is preclinical: no human implant yet, IDE application planned for 2026.Sun, 05 Jul 2026 00:00:00 GMTmarketmarketNia-TherapeuticsSNSSmart-Neurostimulation-SystemFDA-Breakthrough-Device-DesignationTBIepisodic-memoryMichael-KahanaDaniel-RizzutoDARPARestoring-Active-MemoryUniversity-of-PennsylvaniaAllston-Massachusettsclosed-loop-neurostimulationNeuralink performs its first transdural implant on a Canadian ALS patienthttps://insidebci.com/news/2026-07-04-neuralink-first-transdural-canadian-als-lee-marten-uhn-toronto-western/https://insidebci.com/news/2026-07-04-neuralink-first-transdural-canadian-als-lee-marten-uhn-toronto-western/Sgt Lee Marten of the Vancouver Police Department received a Neuralink N1 implant at Toronto Western Hospital on 20 May 2026, becoming the first Canadian ALS patient in the CAN-PRIME trial and the first human anywhere to receive the implant via Neuralink's new transdural surgical technique that preserves the dura rather than cutting it open. The story was broken by CBC News and MobiHealthNews on 2 July 2026.Sat, 04 Jul 2026 00:00:00 GMTnewsnewsNeuralinkCAN-PRIMEtransduralALSCanadaUniversity-Health-NetworkToronto-Western-HospitalAndres-LozanoLee-MartenVancouver-PoliceN1Health-CanadaChina's NMPA locks BCI device classification: every implant is Class III, one narrow Class II lanehttps://insidebci.com/policy/2026-07-04-nmpa-announcement-24-2026-bci-medical-device-classification-guidelines/https://insidebci.com/policy/2026-07-04-nmpa-announcement-24-2026-bci-medical-device-classification-guidelines/China's National Medical Products Administration issued Announcement No. 24 (2026) on 29 June 2026, releasing final Guiding Principles for the Classification and Definition of Brain-Computer Interface Medical Device Products plus a companion Generic Naming Guidelines. Every invasive BCI is Class III. Non-invasive BCIs are Class III by default. Non-invasive stroke-motor rehabilitation devices are Class II only if they do not incorporate artificial intelligence.Sat, 04 Jul 2026 00:00:00 GMTpolicypolicyChinaNMPAAnnouncement-24-2026medical-device-classificationBCI-regulationClass-IIClass-IIIinvasive-BCInon-invasive-BCIstroke-motor-rehabilitationAI-medical-devicesNIFDCIndustrial-Builder-postureGestala closes US$62 million Angel+ round for ultrasound BCI, opens Shanghai NeuroAI headquartershttps://insidebci.com/market/2026-07-03-gestala-china-ultrasound-bci-62m-angel-plus-shanghai-headquarters/https://insidebci.com/market/2026-07-03-gestala-china-ultrasound-bci-62m-angel-plus-shanghai-headquarters/Gestala (格式塔科技), a Chinese non-invasive ultrasound brain-computer interface company led by founder and CEO Phoenix Peng, announced on 3 July 2026 that it had closed a US$62 million Angel+ financing round and formally opened a Shanghai NeuroAI headquarters. The company is the third Chinese ultrasound BCI startup to disclose funding within ten days, alongside Sisen Technology (1 July 2026) and Huachao Shenkong.Fri, 03 Jul 2026 00:00:00 GMTmarketmarketChinaGestalaultrasound-BCIfunctional-ultrasoundPhoenix-PengPeng-LeiHuaying-CapitalFeng-JianfengTrevor-RobbinsBashar-BadranHuachao-ShenkongSisen-TechnologyIndustrial-Builder-postureShanghai-MinhangChengdu-Chantou-28The company behind the Argus II retinal implant is heading back to Nasdaq via reverse merger with ClearOnehttps://insidebci.com/market/2026-07-02-vivani-cortigent-clearone-reverse-merger-nasdaq-visual-cortical-prosthesis/https://insidebci.com/market/2026-07-02-vivani-cortigent-clearone-reverse-merger-nasdaq-visual-cortical-prosthesis/Vivani Medical announced on 2 July 2026 an all-stock reverse-merger agreement to combine its Cortigent subsidiary with Nasdaq-listed ClearOne, forming Cortigent Holdings, Inc. under the expected ticker CRGT. Vivani will hold between 59.4 and 67.5 per cent of the combined company; the deal requires a concurrent 10 to 15 million dollar registered offering and is targeted to close in the third quarter of 2026.Thu, 02 Jul 2026 00:00:00 GMTmarketmarketCortigentVivani-MedicalClearOnereverse-mergerNasdaqSecond-SightArgus-IIOrionvisual-cortical-prosthesisThinkEquityAdam-MendelsohnJonathan-AdamsAn Imperial-Tsinghua BCI lets ten healthy people control a pair of extra robotic arms while balancing a ball with their own handshttps://insidebci.com/research/2026-07-02-farina-imperial-tsinghua-southeast-tactile-p300-supernumerary-bci-nature-communications/https://insidebci.com/research/2026-07-02-farina-imperial-tsinghua-southeast-tactile-p300-supernumerary-bci-nature-communications/Tianyu Jia and Dario Farina at Imperial College London, with collaborators at Tsinghua University and Southeast University Nanjing, published a Nature Communications paper on 2 July 2026 describing a tactile-encoded non-invasive BCI in which ten healthy participants controlled four supernumerary robotic degrees of freedom concurrently with a bimanual ball-balancing task, reaching 74.79 per cent single-task and 59.69 per cent dual-task online accuracy after three days of training.Thu, 02 Jul 2026 00:00:00 GMTresearchresearchImperial-College-LondonTsinghua-UniversitySoutheast-UniversityDario-FarinaTianyu-Jianon-invasive-BCIEEGsupernumerary-effectorstactile-P300augmentationhealthy-participantsNature-CommunicationsHybridNeuroSisen Technology, a Tsinghua-and-ETH ultrasonic BCI startup, raises tens of millions of yuan for glioblastoma drug deliveryhttps://insidebci.com/market/2026-07-01-sisen-technology-tsinghua-eth-ultrasonic-bci-seed-round-glioblastoma/https://insidebci.com/market/2026-07-01-sisen-technology-tsinghua-eth-ultrasonic-bci-seed-round-glioblastoma/Sisen Technology, founded in December 2025 by Tsinghua and ETH Zurich alumni, raised tens of millions of yuan in seed funding co-led by Inno Angel Fund and Tsinghua Alumni Seed Fund, targeting glioblastoma blood-brain-barrier opening as its first indication.Wed, 01 Jul 2026 00:00:00 GMTmarketmarketChinaSisen-Technologyultrasonic-BCIglioblastomablood-brain-barrierTsinghua-UniversityETH-ZurichInno-Angel-FundTsinghua-Alumni-Seed-FundYan-YimoIndustrial-Builder-postureA Bath-and-Ulster EEG headset lifts covert-consciousness detection in brain-injury patients from 39 to 69 per centhttps://insidebci.com/research/2026-07-01-university-of-bath-du-bois-coyle-covert-consciousness-eeg-bci-nature-communications-medicine/https://insidebci.com/research/2026-07-01-university-of-bath-du-bois-coyle-covert-consciousness-eeg-bci-nature-communications-medicine/Naomi du Bois and Damien Coyle at the University of Bath and Ulster University published a Nature Communications Medicine paper on 17 April 2026, press-released by Bath on 30 June, showing a multi-session wearable EEG motor-imagery BCI lifted minimally-conscious-state detection from 39 to 69 per cent across 42 brain-injury patients.Wed, 01 Jul 2026 00:00:00 GMTresearchresearchUniversity-of-BathUlster-UniversityInstitute-for-the-Augmented-HumanNaomi-du-BoisDamien-Coylecovert-consciousnessdisorders-of-consciousnessEEG-BCImotor-imageryminimally-conscious-stateNature-Communications-MedicineNCT03827187Meta's Brain2Qwerty v2 hits 61 per cent word accuracy decoding typed sentences from MEGhttps://insidebci.com/research/2026-06-30-meta-brain2qwerty-v2-meg-non-invasive-brain-to-text-61-percent/https://insidebci.com/research/2026-06-30-meta-brain2qwerty-v2-meg-non-invasive-brain-to-text-61-percent/Meta AI released Brain2Qwerty v2 on 29 June 2026: a non-invasive system that decoded typed sentences from MEG brain signals at 61 per cent average word accuracy across nine healthy volunteers.Tue, 30 Jun 2026 00:00:00 GMTresearchresearchMeta-AIMeta-FAIRBrain2Qwertynon-invasive-BCIMEGJean-Remi-Kingbrain-to-textBCBLConformer-architectureAurenar's V-Link ear-worn vagus-nerve stimulator receives FDA Breakthrough Device Designation for cerebral vasospasm in aneurysmal subarachnoid hemorrhagehttps://insidebci.com/market/2026-06-30-aurenar-v-link-fda-breakthrough-cerebral-vasospasm-asah/https://insidebci.com/market/2026-06-30-aurenar-v-link-fda-breakthrough-cerebral-vasospasm-asah/Aurenar, a Washington University neurosurgery spinout led by Eric Leuthardt, received FDA Breakthrough Device Designation on 30 June 2026 for the V-Link System, a non-invasive transauricular vagus nerve stimulator targeting cerebral vasospasm in aneurysmal subarachnoid hemorrhage patients.Tue, 30 Jun 2026 00:00:00 GMTmarketmarketAurenarV-LinktaVNStransauricular-vagus-nerve-stimulationFDA-BreakthroughEric-LeuthardtWashUaneurysmal-subarachnoid-hemorrhagecerebral-vasospasmbioelectronic-medicineA Chalmers-led review argues visual and somatosensory cortical prostheses have converged into one engineering problemhttps://insidebci.com/research/2026-06-30-chalmers-valle-cortical-microstimulation-vision-touch-review-nature-bioengineering/https://insidebci.com/research/2026-06-30-chalmers-valle-cortical-microstimulation-vision-touch-review-nature-bioengineering/Giacomo Valle at Chalmers and co-authors from Pittsburgh, Amsterdam and Miguel Hernández University published a Nature Reviews Bioengineering paper on 1 June 2026 arguing that fifty years of parallel work on visual and somatosensory cortical microstimulation prostheses have converged into a single engineering discipline.Tue, 30 Jun 2026 00:00:00 GMTresearchresearchChalmersGiacomo-ValleNature-Reviews-Bioengineeringcortical-microstimulationvisual-prosthesissomatosensory-prosthesisICMSsense-restorationPieter-RoelfsemaEduardo-FernandezRobert-GauntFluent, a University of Melbourne spinout, raises over two million dollars for a sub-scalp EEG speech-decoding implanthttps://insidebci.com/market/2026-06-30-fluent-university-of-melbourne-sub-scalp-eeg-speech-decoding-seed-round/https://insidebci.com/market/2026-06-30-fluent-university-of-melbourne-sub-scalp-eeg-speech-decoding-seed-round/Fluent, a Melbourne biomedical engineering spinout founded in May 2025, has raised over two million dollars in seed capital to develop InScribe, a sub-scalp EEG device for speech decoding in patients with motor neurone disease and multiple sclerosis, with first-in-human surgery targeted for 2026.Tue, 30 Jun 2026 00:00:00 GMTmarketmarketAustraliaFluentInScribesub-scalp-EEGUniversity-of-MelbourneTim-MahoneyDavid-GraydenDean-FreestoneMNDMSspeech-decodingAleph Neuro reports what it says is the first 3D ultrasound localization microscopy image of a living human brain through an intact skullhttps://insidebci.com/news/2026-06-28-aleph-neuro-butterfly-network-ultrasound-localization-microscopy-3d-human-brain/https://insidebci.com/news/2026-06-28-aleph-neuro-butterfly-network-ultrasound-localization-microscopy-3d-human-brain/San Francisco research lab Aleph Neuro published what it describes as the first 3D ultrasound localization microscopy (ULM) image of a living human brain through an intact skull on 24 June 2026, as a participant in Butterfly Network's Embedded licensing and co-development program.Sun, 28 Jun 2026 00:00:00 GMTnewsnewsAleph-NeuroButterfly-NetworkButterfly-EmbeddedUltrasound-on-Chipultrasound-localization-microscopyULMnon-invasive-BCIfunctional-ultrasoundmicrobubble-contrastSan-FranciscoJoseph-DeVivoJonathan-RothbergForest-NeurotechIconeusStanford maps the human precentral gyrus at single-neuron resolution across eight paralysed BCI participantshttps://insidebci.com/research/2026-06-28-stanford-deo-willett-henderson-mosaic-precentral-gyrus-bci-target-map/https://insidebci.com/research/2026-06-28-stanford-deo-willett-henderson-mosaic-precentral-gyrus-bci-target-map/A Stanford-led BrainGate study across eight paralysed participants and 20 microelectrode arrays, published in Nature on 17 June 2026, finds whole-body representation at every sampled location of the precentral gyrus.Sun, 28 Jun 2026 00:00:00 GMTresearchresearchStanford-NPTLBrainGate2precentral-gyrusmotor-cortexPenfield-homunculussingle-neuron-recordingspeech-BCIelectrode-placementimplantable-BCIKorea's Ybrain electroceutical startup restarts its stalled KOSDAQ IPOhttps://insidebci.com/market/2026-06-28-ybrain-kosdaq-ipo-revival-ceragem-nh-investment-securities/https://insidebci.com/market/2026-06-28-ybrain-kosdaq-ipo-revival-ceragem-nh-investment-securities/Korean depression-tDCS device maker Ybrain has restarted its KOSDAQ IPO process in 2026, with Ceragem holding a 41.19 percent stake and NH Investment & Securities as lead bookrunner. Listing is targeted for early 2027.Sun, 28 Jun 2026 00:00:00 GMTmarketmarketSouth-KoreaYbrainKOSDAQCeragemNH-Investment-SecuritiesMINDD-STIMelectroceuticalK-MoonshotIndustrial-Builder-postureGuangdong's 2026-2030 BCI Action Plan targets 10 billion yuan and names Guangzhou and Shenzhen as twin anchorshttps://insidebci.com/policy/2026-06-26-guangdong-bci-action-plan-2026-2030-dual-core-guangzhou-shenzhen/https://insidebci.com/policy/2026-06-26-guangdong-bci-action-plan-2026-2030-dual-core-guangzhou-shenzhen/Guangzhou and Shenzhen will split the work of building China's most ambitious provincial brain-computer interface industry under a 'Dual-Core' Action Plan released 24 June 2026: 10 billion yuan core industry, 100 new enterprises, 200 BCI hospital wards by 2030.Fri, 26 Jun 2026 00:00:00 GMTpolicypolicyChinaGuangdongGuangzhouShenzhenBCI-Action-PlanDual-CorePazhou-LaboratoryZhujiang-HospitalIndustrial-Builder-postureprovincial-implementation100-new-enterprisesLi-YuanqingSeven-Ministry-OpinionsMIITNDRCnational-to-provincial-cascadeActivateNeuro launches with $2.9M and a Battelle license for the NeuroLife sleeve for stroke and SCI rehabhttps://insidebci.com/news/2026-06-25-activate-neuro-neurolife-battelle-spinout-2-9m-seed-stroke-rehabilitation/https://insidebci.com/news/2026-06-25-activate-neuro-neurolife-battelle-spinout-2-9m-seed-stroke-rehabilitation/ActivateNeuro launched on 25 June 2026 with $2.9M and a license to Battelle's non-invasive NeuroLife sleeve, an sEMG-driven FES wearable for stroke and spinal cord injury hand rehabilitation.Thu, 25 Jun 2026 00:00:00 GMTnewsnewsActivateNeuroNeuroLifeBattelleNeuroTech-Institutewearable-neurotechstroke-rehabilitationspinal-cord-injurysEMGFESJon-SnyderOhio-Statenon-invasiveVice Premier Liu Guozhong calls BCI 'a key area of international industrial competition' at Nanjing Universityhttps://insidebci.com/policy/2026-06-25-china-vice-premier-liu-guozhong-nanjing-university-bci-research-institute/https://insidebci.com/policy/2026-06-25-china-vice-premier-liu-guozhong-nanjing-university-bci-research-institute/Vice Premier Liu Guozhong inspected the Brain-Computer Interface Research Institute at Nanjing University on 22-23 June 2026, naming BCI a 'key area of international industrial competition' per Xinhua and NJU.Thu, 25 Jun 2026 00:00:00 GMTpolicypolicyChinaLiu-GuozhongVice-PremierNanjing-UniversityNJUBrain-Computer-Interface-Research-InstituteHealthy-ChinaIndustrial-Builder-postureXinhuabiomedicine-pillar-industryZhang-GuoqingNeural Drive, a Singapore non-invasive BCI wearable startup, raises US$250K pre-seed from Afore Capitalhttps://insidebci.com/news/2026-06-23-neural-drive-singapore-sutd-startup-afore-capital-pre-seed/https://insidebci.com/news/2026-06-23-neural-drive-singapore-sutd-startup-afore-capital-pre-seed/Singapore's Neural Drive raised a US$250K pre-seed from Afore Capital for a non-invasive EEG/EOG wearable designed for paralysed users, per a Singapore University of Technology and Design release on 23 June 2026.Tue, 23 Jun 2026 00:00:00 GMTnewsnewsNeural-DriveSingaporeSUTDAfore-Capitalnon-invasive-BCIEEG-EOG-wearablepre-seedFounders-in-ResidenceTan-Tock-Seng-HospitalSoutheast-Asia-BCIThree patients received a 30-minute test of Coherence Neuro's brain-tumor implant at Royal Melbourne Hospitalhttps://insidebci.com/news/2026-06-23-coherence-neuro-brain-tumor-implant-royal-melbourne-hospital-three-patients/https://insidebci.com/news/2026-06-23-coherence-neuro-brain-tumor-implant-royal-melbourne-hospital-three-patients/Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.Tue, 23 Jun 2026 00:00:00 GMTnewsnewsCoherence-Neurobrain-tumorglioblastomaRoyal-Melbourne-HospitalBCI-cancerNeuralink-tiesMatthew-MacDougallBen-WoodingtonOptuneelectroceuticalCIPHERfirst-in-humanNeuracle, maker of the world's first approved invasive BCI, files for a Shanghai STAR Market IPO with RMB 2.5B target raisehttps://insidebci.com/market/2026-06-22-neuracle-star-market-ipo-prospectus-accepted-brainco-race/https://insidebci.com/market/2026-06-22-neuracle-star-market-ipo-prospectus-accepted-brainco-race/Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.Mon, 22 Jun 2026 00:00:00 GMTmarketmarketNeuracleBoruikangChinaSTAR-MarketShanghai-Stock-ExchangeIPOBrainCoCITIC-SecuritiesNEO-implantfirst-BCI-IPOTsinghua-spinoutConnecticut and Vermont activate neural data privacy laws on 1 July, taking the US count to five stateshttps://insidebci.com/policy/2026-06-21-connecticut-vermont-neural-data-privacy-1-july-five-states/https://insidebci.com/policy/2026-06-21-connecticut-vermont-neural-data-privacy-1-july-five-states/Connecticut's Public Act 25-113 (SB 1295), signed by Governor Ned Lamont on 25 June 2025, takes effect on 1 July 2026 and adds 'any information that is generated by measuring the activity of an individual's central nervous system' to the Connecticut Data Privacy Act's sensitive-data category. Vermont's Act 101 (H.814), signed 18 May 2026, takes effect the same day. After 1 July, Colorado, California, Montana, Connecticut and Vermont will all have active neural data privacy law on the books. Connecticut's definition is the narrowest of the five.Sun, 21 Jun 2026 00:00:00 GMTpolicypolicyneural-data-privacyConnecticutVermontSB-1295H814CTDPAAct-101Public-Act-25-113state-patchworkUS-policysensitive-dataNed-LamontPhil-ScottJames-MaroneyBrian-CinaChina and South Korea have shipped three BCI industrial-policy launches in eight weekshttps://insidebci.com/market/2026-06-21-three-bci-industrial-policy-launches-china-south-korea-eight-weeks/https://insidebci.com/market/2026-06-21-three-bci-industrial-policy-launches-china-south-korea-eight-weeks/Between 1 May and 19 June 2026, three operational state-backed brain-computer interface moves landed across China and South Korea. China State Council Order No. 818 took effect on 1 May 2026, opening a parallel commercial pathway for advanced biomedical technologies that names BCI explicitly. Tianjin formally inaugurated a dedicated BCI industrial cluster with 100 million yuan in annual funding on 29 May 2026. South Korea launched its first national BCI industry association in Seoul on 16 June 2026, anchored to the K-Moonshot strategic R&D mission. Three dated, named, primary-sourced moves in eight weeks across two jurisdictions.Sun, 21 Jun 2026 00:00:00 GMTmarketmarketIndustrial-Builder-postureChinaSouth-KoreaOrder-818Tianjin-clusterKorean-BCI-AssociationK-MoonshotCho-Il-jooBaek-Nam-jongYbrainHaihe-Laboratoryindustrial-policyAsia-PacificKorea's BCI industry forms a national association in Seoul, anchored to the K-Moonshot state programmehttps://insidebci.com/market/2026-06-19-korea-bci-industry-association-launch-centerfield-baek-nam-jong/https://insidebci.com/market/2026-06-19-korea-bci-industry-association-launch-centerfield-baek-nam-jong/The Korean BCI Association (한국BCI협회) held its inaugural general meeting on Tuesday 16 June 2026 at Centerfield in Gangnam-gu, Seoul. Seoul National University Hospital President Baek Nam-jong was elected inaugural chair. Standing vice president is Kim Yong-jin, who chairs ISO/IEC JTC 1 SC 41 (Internet of Things and Digital Twin). Founding members include Ybrain, Dynamic Solution, Vibatrobotics, Ceragem on the industry side; Seoul National University Hospital, Severance Hospital and Korea University Anam Hospital on the medical side; and KAIST, DGIST, UNIST, Korea University, Catholic Kwandong University, Yonsei University and Hanyang University on the academic side. The association states it will actively support the K-Moonshot strategic R&D programme that launched in March 2026 with 12 missions, including a BCI mission led by Korea University Professor Cho Il-joo.Fri, 19 Jun 2026 00:00:00 GMTmarketmarketSouth-KoreaKorean-BCI-AssociationK-MoonshotBaek-Nam-jongCho-Il-jooYbrainSeoul-National-University-HospitalISO-IEC-JTC-1-SC-41Kim-Yong-jinindustrial-policyIndustrial-Builder-postureA Michigan woman with motor neuron disease has received the first Paradromics Connexus brain implanthttps://insidebci.com/news/2026-06-17-paradromics-first-connexus-bci-implant-michigan-connect-one/https://insidebci.com/news/2026-06-17-paradromics-first-connexus-bci-implant-michigan-connect-one/Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.Wed, 17 Jun 2026 00:00:00 GMTnewsnewsbrain-computer-interfaceBCIParadromicsConnexusConnect-OneUniversity-of-MichiganUC-DavisMass-GeneralFDA-IDEmotor-neuron-diseaseALSMatt-AngleDavid-BrandmanMatthew-WillseyAustin-TexasItaly's WISE has raised €30 million for spinal cord stimulation, with ENEA Tech entering as strategic investorhttps://insidebci.com/market/2026-06-17-wise-series-d-30-million-euro-spinal-cord-stimulation-italy/https://insidebci.com/market/2026-06-17-wise-series-d-30-million-euro-spinal-cord-stimulation-italy/WISE S.p.A., an Italian implantable-electrode company working in neuromonitoring, neuromodulation and BCI, closed an oversubscribed €30 million ($34.8M) Series D on 17 June 2026. The lead application is the company's Heron percutaneous spinal cord stimulation lead.Wed, 17 Jun 2026 00:00:00 GMTmarketmarketfundingWISEENEA-Techspinal-cord-stimulationSCSneuromodulationneuromonitoringbioelectronic-medicineHeron-leadItalySupersonic-Technologyimplantable-electrodesTianjin has formally opened a brain-computer interface industrial cluster backed by 100 million yuan in annual fundinghttps://insidebci.com/market/2026-06-17-tianjin-bci-industrial-cluster-100-million-yuan-china/https://insidebci.com/market/2026-06-17-tianjin-bci-industrial-cluster-100-million-yuan-china/Per China Daily, the city of Tianjin formally inaugurated a dedicated BCI industrial cluster at the 2026 World Intelligence Expo, with 100 million yuan (about $14.8M) annual funding committed, 22 BCI companies already incubated in the zone, and a target of 50 enterprises by 2027.Wed, 17 Jun 2026 00:00:00 GMTmarketmarketChinaTianjinBCI-industrial-clusterHaihe-LaboratoryWorld-Intelligence-Expo-2026Tianjin-Brain-Computer-Interface-Industry-GroupTianjin-Huanhu-Hospitalindustrial-policyChina-BCI-cohortcommercial-scale-upnon-invasive-BCIA man with ALS has used his speech brain implant at home for nearly two years, mostly on his ownhttps://insidebci.com/research/2026-06-16-als-power-user-brain-implant-home-3800-hours-ucdavis/https://insidebci.com/research/2026-06-16-als-power-user-brain-implant-home-3800-hours-ucdavis/Casey Harrell, who has ALS, used a UC Davis intracortical speech BCI at home for more than 3,800 hours over 22 months without researchers present. Nature Medicine published the case on 15 June 2026.Tue, 16 Jun 2026 00:00:00 GMTresearchresearchbrain-computer-interfaceBCIintracortical-BCIspeech-BCIALSCasey-HarrellUC-Davis-Neuroprosthetics-LabDavid-BrandmanSergey-StaviskyNicholas-CardNature-MedicineBrainGate2A Yale fMRI brain-computer interface cuts training time to under an hour by following the brain's natural geometryhttps://insidebci.com/research/2026-06-11-yale-bci-manifold-geometry-cuts-training-time/https://insidebci.com/research/2026-06-11-yale-bci-manifold-geometry-cuts-training-time/Yale's Nature Neuroscience study reports that healthy participants learned to control a video game avatar in under an hour when the fMRI decoder followed each user's individual neural manifold. Off-manifold mappings produced no learning at all.Thu, 11 Jun 2026 00:00:00 GMTresearchresearchbrain-computer-interfaceBCIfMRIneural-manifoldT-PHATEYale-UniversityNature-Neurosciencedecoder-designBCI-trainingErica-BuschSmita-KrishnaswamyNick-Turk-BrowneJeff Bezos has just become the only tech billionaire investing across multiple layers of neurotechhttps://insidebci.com/opinion/2026-06-07-bezos-multiple-layers-neurotech-only-tech-billionaire-velco-dar/https://insidebci.com/opinion/2026-06-07-bezos-multiple-layers-neurotech-only-tech-billionaire-velco-dar/In June 2026 Bezos's capital crossed into brain-inspired AI (Flourish, close to $100M at $2.5B) and basic neuroscience (Allen Institute family gift, $100M). With Bezos Expeditions in Synchron, no other tech billionaire spans this many neurotech layers.Sun, 07 Jun 2026 00:00:00 GMTopinionopinionbezos-familybezos-expeditionssynchronflourishallen-institute-brain-healthus-neurotech-capital-structurethomas-reardontech-billionaire-neurotechconcentration-riskdargentic-intelligenceJeff Bezos puts nearly $100M into Internet Explorer creator Thomas Reardon's new brain-inspired AI startup, in a $500M round at a $2.5B valuationhttps://insidebci.com/market/2026-06-06-flourish-bezos-100m-reardon-brain-inspired-ai-500m-2-5b-valuation/https://insidebci.com/market/2026-06-06-flourish-bezos-100m-reardon-brain-inspired-ai-500m-2-5b-valuation/Flourish, a New York neuro-AI startup founded in 2024 by Thomas Reardon (Internet Explorer architect at Microsoft in 1994 and CTRL-labs co-founder who sold the company to Meta in 2019 for between $500 million and $1 billion) and former Amazon S-team executive Rob Williams, closed a $500 million round at a $2.5 billion valuation around 4 June 2026. Jeff Bezos contributed close to $100 million after nearly doubling an initial $50 million commitment. Other investors include Lux Capital, GV (Alphabet), and Catalio Capital. The company is building Cortex AI, an architecture-layer system that uses connectomics, the cell-by-cell mapping of biological neural connections, to design AI models that target 20-50 watts of energy draw, roughly the power consumption of a laptop and an order of magnitude lower than a server-grade GPU. Flourish has no product yet.Sat, 06 Jun 2026 00:00:00 GMTmarketmarketflourishthomas-reardonjeff-bezosctrl-labs-lineageconnectomicsbrain-inspired-ailux-capitalgvcatalio-capitalcortex-aiai-efficiencyCleveland startup Neuronoff implants its first patient in a US Department of Defense-funded trial of a needle-delivered nerve electrode for bladder control after spinal cord injuryhttps://insidebci.com/news/2026-06-06-neuronoff-first-patient-dod-trial-injectrode-neurogenic-bladder-sci/https://insidebci.com/news/2026-06-06-neuronoff-first-patient-dod-trial-injectrode-neurogenic-bladder-sci/Neuronoff announced on 5 June 2026 that it has implanted the first patient in a US Department of Defense-funded clinical trial of its Injectrode, a helical platinum-iridium peripheral nerve electrode delivered through a single 18-gauge needle under local anaesthesia, in patients with neurogenic bladder dysfunction following spinal cord injury. The trial (NCT07264868) is being run at UT Health Houston under principal investigator Dr Argyrios Stampas, Associate Professor and Vice Chair of Research and Innovation in the Department of Physical Medicine and Rehabilitation at McGovern Medical School. It is a Phase 1/2 randomised controlled study enrolling 21 participants across three arms (unilateral active stimulation, bilateral active stimulation, sham), with primary endpoints at 4 and 8 weeks assessing safety, stimulation accuracy, procedural feasibility, and physician and patient acceptability. This is the first-in-human spinal cord injury trial of the Injectrode.Sat, 06 Jun 2026 00:00:00 GMTnewsnewsneuronoffinjectrodeneurogenic-bladderspinal-cord-injuryus-dod-funded-trialut-health-houstonargyrios-stampasphase-1-2-trialperipheral-nerve-stimulationbioelectronic-medicineAllen Institute launches $400M Brain Health accelerator with Bezos family and AWS, naming ALS as one of five focus diseaseshttps://insidebci.com/market/2026-06-05-allen-institute-brain-health-accelerator-400m-bezos-aws-als/https://insidebci.com/market/2026-06-05-allen-institute-brain-health-accelerator-400m-bezos-aws-als/The Allen Institute announced on 2 June 2026 a $400 million global research initiative called the Brain Health accelerator, targeting neurodegenerative disease at the cell and circuit level. Capital is $200 million from the Allen Institute, $100 million from the Bezos family (whose Bezos Expeditions arm backs Synchron), and $100 million combined from AWS, NIH, and ALS advocacy organisation EverythingALS. The ALS focus is the most direct adjacency to the implantable BCI cohort, which has anchored most of its early commercial work on ALS patients.Fri, 05 Jun 2026 00:00:00 GMTmarketmarketallen-institutebrain-health-acceleratorbezos-familyawseverythingalsneurodegenerationals-researchnih-brain-initiativerui-costaed-leinphilanthropic-neuroscienceNeuralink hires its first federal lobbyists to open the brain-computer interface coverage accounthttps://insidebci.com/policy/2026-06-03-neuralink-first-federal-lobbyists-kimbell-arnold-porter-ron-kind-medicare-coverage/https://insidebci.com/policy/2026-06-03-neuralink-first-federal-lobbyists-kimbell-arnold-porter-ron-kind-medicare-coverage/Newly filed federal disclosures show that Neuralink has engaged Jeffrey J. Kimbell & Associates and Arnold & Porter Kaye Scholer as its first registered federal lobbyists, with both firms beginning work at the end of April 2026. The scope explicitly names brain-computer interface development and commercialisation plus 'coverage of such devices' as the lobbying focus. The team on the Arnold & Porter side includes former 13-term Wisconsin Democratic Rep. Ron Kind, Senior Counsel at the firm since January 2024 and a former House Ways and Means Committee member overseeing Medicare payment programs. The hire is the first publicly visible step Neuralink has taken toward US Medicare reimbursement positioning for the N1 implant.Wed, 03 Jun 2026 00:00:00 GMTpolicypolicyneuralinkfederal-lobbyingron-kindkimbell-associatesarnold-portermedicare-coveragebci-reimbursementn1-implanthouse-ways-and-meansus-policyFrance's CEA-Leti opens new clinical trial taking its brain implant from paralysis recovery into post-stroke rehabilitationhttps://insidebci.com/news/2026-06-03-cea-leti-bci4stroke-wimagine-post-stroke-rehabilitation/https://insidebci.com/news/2026-06-03-cea-leti-bci4stroke-wimagine-post-stroke-rehabilitation/France's CEA-Leti announced on 3 June 2026 that it has applied for regulatory authorization to begin BCI4Stroke, a brain-computer interface clinical trial extending the WIMAGINE epidural implant platform into post-stroke rehabilitation. The trial is registered on ClinicalTrials.gov as NCT07477613. WIMAGINE is the same platform that produced the 2019 tetraplegic exoskeleton walking demonstration (Benabid et al., Lancet Neurology) and the 2023 brain-spine interface paralysed-man-walks result with Gert-Jan Oskam (Lorach et al., Nature, the Courtine and Bloch programme). BrainSync is funded under France's €40 million Audace! research programme (France 2030) and the European Innovation Council under Horizon Europe.Wed, 03 Jun 2026 00:00:00 GMTnewsnewscea-letiwimaginebrainsyncbci4strokepost-stroke-rehabilitationfrance-2030audace-programmeolivier-detantelucas-struberserpil-karakasclinateceuropean-bcihorizon-europeIrish patient with motor neurone disease uses his Neuralink brain implant to steer his wheelchair with thoughts alonehttps://insidebci.com/news/2026-05-31-eoin-egan-irish-neuralink-gb-prime-thought-controlled-wheelchair/https://insidebci.com/news/2026-05-31-eoin-egan-irish-neuralink-gb-prime-thought-controlled-wheelchair/Eoin Egan, a 43-year-old Roscommon-born architect and property consultant living in London with motor neurone disease, has gone public as one of seven UK participants in Neuralink's GB-PRIME early feasibility study. Egan received his N1 Implant in December 2025 at UCLH's National Hospital for Neurology and Neurosurgery (Queen Square) in a six-hour robot-performed operation. Four days post-surgery he was driving his wheelchair through a London park with his thoughts alone, using bespoke software built by German assistive technology firm Homebrace that links the BCI cursor to wheelchair steering. He is the third UK GB-PRIME participant to surface publicly, after Paul (October 2025, also MND) and Sebastian Gomez (medical student paralysed in a diving accident).Sun, 31 May 2026 00:00:00 GMTnewsnewsneuralinkgb-primeuclhqueen-squareharith-akramwilliam-muirheadmotor-neurone-diseasethought-controlled-wheelchairhomebraceuk-bcieoin-eganAustralian brain-mapping company Omniscient closes $27.2M Series D, naming brain-computer interfaces as a target expansion markethttps://insidebci.com/market/2026-05-29-omniscient-27m-series-d-connectomics-bci-expansion/https://insidebci.com/market/2026-05-29-omniscient-27m-series-d-connectomics-bci-expansion/Sydney and San Francisco-based Omniscient Neurotechnology closed a $27.2 million (AU$41.1 million) Series D funding round on 29 May 2026, co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation. The capital scales the company's FDA-cleared Quicktome connectomics platform for neurosurgical planning, with the company explicitly naming brain-computer interface, stroke, and movement disorders as the next expansion indications. Omniscient is a connectomics company rather than a BCI implant company; the BCI angle is forward-looking adjacency rather than current product.Fri, 29 May 2026 00:00:00 GMTmarketmarketomniscient-neurotechnologyquicktomeconnectomicsbrain-mappingseries-doif-venturesaustralian-national-reconstruction-fundstephen-scheelerbci-adjacencyRice University and Baylor College of Medicine join BrainGate, becoming the consortium's first Texas site and sixth team overallhttps://insidebci.com/news/2026-05-29-rice-baylor-join-braingate-sixth-team-texas-first/https://insidebci.com/news/2026-05-29-rice-baylor-join-braingate-sixth-team-texas-first/Rice University and Baylor College of Medicine announced on 28 May 2026 that they have joined the BrainGate research consortium, the multi-institutional clinical brain-computer interface network founded by John Donoghue at Brown University. The Texas team is the sixth in the consortium and the first based outside the eastern and western US clusters. The Rice-Baylor work focuses on decoding cortical neural signals to operate assistive robotic devices that help people with tetraplegia eat and drink independently. The expansion lands the same week Donoghue was named a 2026 Queen Elizabeth Prize for Engineering co-laureate for his BrainGate-anchored work.Fri, 29 May 2026 00:00:00 GMTnewsnewsbraingaterice-universitybaylor-college-of-medicinenishal-shahsameer-shethnicole-provenzaleigh-hochbergtexas-bci-clustertetraplegiaassistive-roboticsintracortical-bciTencent takes a minority stake in Hangzhou brain-chip developer Nanochap Electronicshttps://insidebci.com/market/2026-05-29-tencent-takes-stake-nanochap-bci-chip-hangzhou/https://insidebci.com/market/2026-05-29-tencent-takes-stake-nanochap-bci-chip-hangzhou/Tencent Holdings has acquired a minority equity stake in Nanochap Electronics, a Hangzhou-based fabless semiconductor company specialising in neural interface and biosensing SoCs for brain-computer interface and medical device applications. The investment was disclosed through a 28 May 2026 business registration filing showing Shanghai Qishan Investment, a Tencent subsidiary, added as a new shareholder. Nanochap's registered capital increased to RMB 16.8853 million. Exact stake size and investment amount have not been publicly disclosed. The move follows the April 2026 StairMed funding round in which Alibaba led and Tencent joined, and signals a sustained pattern of Chinese big-tech equity participation in the country's BCI silicon supply chain.Fri, 29 May 2026 00:00:00 GMTmarketmarkettencentnanochap-electronicschina-bcihangzhoubci-supply-chainneural-interface-chipsshanghai-qishan-investmentfabless-semiconductorchinese-big-tech-bciNeuroXess says its Mandarin-decoding brain implant runs at 300 characters a minute, faster than native speechhttps://insidebci.com/news/2026-05-28-neuroxess-mandarin-bci-300-cpm-llm-decoder/https://insidebci.com/news/2026-05-28-neuroxess-mandarin-bci-300-cpm-llm-decoder/Shanghai-based NeuroXess says a 35-year-old woman with epilepsy fitted with its 256-channel surface-cortex implant has been decoded reading Mandarin at 300 characters per minute through a large language model layer, faster than the roughly 220 cpm rate of a native Mandarin first-language speaker. Co-founder and chief scientist Tiger Tao disclosed the figure to Nature on 19 May 2026. The underlying paper has not yet been published, but the result sits on top of NeuroXess's already peer-reviewed Science Advances paper from 5 November 2025 (71.2% accuracy across 394 Mandarin syllables in a 43-year-old woman with epilepsy).Thu, 28 May 2026 00:00:00 GMTnewsnewsneuroxesschina-bcimandarin-decodingtiger-taohuashan-hospitalshanghaillm-bciai-decoderspinal-cord-injuryepilepsyimplantable-bciscience-advancesONWARD Medical posts EUR 2M Q1 revenue, advances ARC-BCI to seven implanted participants, begins Empower BP pivotal at Craig Hospitalhttps://insidebci.com/market/2026-05-27-onward-medical-q1-2026-results-arc-bci-seven-implants-empower-bp/https://insidebci.com/market/2026-05-27-onward-medical-q1-2026-results-arc-bci-seven-implants-empower-bp/ONWARD Medical reported Q1 2026 results on 26 May 2026 with EUR 2.0 million in revenue (EUR 1.3 million ARC-EX systems across 100+ clinics, 70 systems supplied including first home-use shipments to US VA patients), two additional ARC-BCI participants bringing the total to seven, and first participant enrolled plus first implant in the Empower BP pivotal study at Craig Hospital, Denver. The company holds EUR 53.4 million in cash before adding over EUR 40 million from the April equity raise, extending runway into Q1 2028.Wed, 27 May 2026 00:00:00 GMTmarketmarketonward-medicalarc-bciarc-exempower-bpcraig-hospitalspinal-cord-injuryearningsbrain-spine-interfaceeuronext-onwdSwiss BCI startup ABILITY Neurotech wins Dutch regulatory approval to begin first chronic implantation of its fully implantable wireless BCI in ALS patientshttps://insidebci.com/news/2026-05-27-ability-neurotech-imdd-approval-first-chronic-bci-als-utrecht/https://insidebci.com/news/2026-05-27-ability-neurotech-imdd-approval-first-chronic-bci-als-utrecht/ABILITY Neurotech, the Geneva-based Wyss Center spinout building Europe's first fully implantable wireless optical-link ECoG brain-computer interface, received Investigational Medical Device Dossier (IMDD) approval from MREC NedMec in the Netherlands on 26 May 2026 to begin the first chronic implantation study of its device in ALS patients at UMC Utrecht under the INTRECOM consortium.Wed, 27 May 2026 00:00:00 GMTnewsnewsability-neurotechwyss-centerumc-utrechtintrecom-consortiumalsecog-bcifully-implantable-bcioptical-linkrotem-kopelmariska-vansteenseleuropean-bciBelgian ReVision Implant closes €4M oversubscribed seed for cortical vision prosthesis, with first-in-human trial cleared for Q3 2026https://insidebci.com/news/2026-05-27-revision-implant-4-million-seed-occular-cortical-vision-prosthesis/https://insidebci.com/news/2026-05-27-revision-implant-4-million-seed-occular-cortical-vision-prosthesis/Belgian neurotech ReVision Implant closed an oversubscribed €4 million seed round in May 2026 to bring manufacturing of its Occular cortical vision prosthesis in-house ahead of a first-in-human trial cleared for Q3 2026 (October surgical-window cohort), with broader early-stage trials in blind volunteers expected in summer 2027. The round follows FDA Breakthrough Device Designation granted in March 2026.Wed, 27 May 2026 00:00:00 GMTnewsnewsrevision-implantoccularvision-restorationcortical-visual-prosthesisbelgium-neurotechseed-fundingfda-breakthrough-deviceumc-utrechtInspire Medical cuts 2026 guidance to $825-875M as CMS WISeR consumes the bull casehttps://insidebci.com/market/2026-05-26-inspire-medical-2026-guidance-cut-wiser-bofa-downgrade/https://insidebci.com/market/2026-05-26-inspire-medical-2026-guidance-cut-wiser-bofa-downgrade/Inspire Medical Systems reported Q1 2026 revenue of $204.6 million (up 1.6% year-on-year) on 4 May 2026 and cut full-year 2026 guidance to $825-875 million from the prior $950 million-$1 billion range issued in February. The company attributed approximately $20 million of Q1 impact to CMS WISeR prior authorization and CPT code transition uncertainty. Bank of America analyst Travis Steed downgraded the stock from Neutral to Underperform.Tue, 26 May 2026 00:00:00 GMTmarketmarketinspire-medicalwisercmscpt-code-64582hypoglossal-nerve-stimulationsleep-apneabofa-downgradetravis-steedneuromodulation-bifurcationRockefeller researchers locate abstract thought in the ventral premotor cortex, opening a new decoding target above motor cortex for brain-computer interfaceshttps://insidebci.com/research/2026-05-26-rockefeller-ventral-premotor-cortex-abstract-thought-bci-decoding/https://insidebci.com/research/2026-05-26-rockefeller-ventral-premotor-cortex-abstract-thought-bci-decoding/Researchers at Rockefeller University's Laboratory of Neural Systems published evidence in Nature that the ventral premotor cortex hosts the neural substrates of abstract symbolic thought, identifying a brain region that mediates between the higher-thinking prefrontal cortex and the action-executing motor cortex. The finding has direct implications for BCI decoding targets: implants placed at the ventral premotor cortex could potentially decode user intent at a higher level of abstraction than current motor-cortex BCIs.Tue, 26 May 2026 00:00:00 GMTresearchresearchventral-premotor-cortexabstract-thoughtrockefeller-universitylaboratory-of-neural-systemscompositional-generalizationnaturebci-decoding-targetscognitive-neuroscienceSynchron CEO Tom Oxley joins Australian founder pushback against Chalmers's CGT proposalhttps://insidebci.com/policy/2026-05-26-tom-oxley-synchron-chalmers-cgt-australian-founder-pushback/https://insidebci.com/policy/2026-05-26-tom-oxley-synchron-chalmers-cgt-australian-founder-pushback/Synchron co-founder and CEO Tom Oxley publicly criticised Treasurer Jim Chalmers's proposed capital gains tax changes in The Australian on 25 May 2026, joining a growing Australian founder coalition arguing the 2026-27 federal budget reforms would push tech talent and startup equity offshore. The Chalmers budget, handed down 12 May 2026, proposes removing the 50% CGT discount from 1 July 2027 and replacing it with cost-based indexation plus a 30% minimum tax on net capital gains.Tue, 26 May 2026 00:00:00 GMTpolicypolicytom-oxleysynchronaustraliacapital-gains-taxjim-chalmersaustralian-tech-policystartup-equitynational-reconstruction-fundanthony-albaneseMost of Europe's leading neurotechnology companies trace back to one Geneva research campushttps://insidebci.com/market/2026-05-26-epfl-lausanne-geneva-neurotechnology-cluster-campus-biotech/https://insidebci.com/market/2026-05-26-epfl-lausanne-geneva-neurotechnology-cluster-campus-biotech/The Friday $7.5 million seed round for Neurosoft Bioelectronics is the latest commercial output from a Lausanne-Geneva neurotechnology cluster anchored on EPFL's Neuro-X Institute at Campus Biotech Geneva. The same cluster has produced ONWARD Medical (now NASDAQ-listed brain-spine interface company), MindMaze (Lausanne-founded brain-technology unicorn), and the academic research that China's brain-spine clinical programmes are now structurally copying.Tue, 26 May 2026 00:00:00 GMTmarketmarketepflneuro-x-institutecampus-biotech-genevaneurosoft-bioelectronicsonward-medicalmindmazestephanie-lacourgregoire-courtinesilvestro-miceradiego-ghezziwyss-centereuropean-neurotechlausanne-clusterChinese paraplegic patient regains partial sensation and movement one year after world-first combined Beinao-1 BCI and brain-spine interface surgeryhttps://insidebci.com/research/2026-05-24-china-beinao-1-brain-spine-joint-interface-paraplegic-recovery/https://insidebci.com/research/2026-05-24-china-beinao-1-brain-spine-joint-interface-paraplegic-recovery/A paraplegic patient who in May 2025 became the world's first to simultaneously receive the invasive Beinao No.1 brain-computer interface and a temporally programmed spinal cord stimulation system has improved from complete to incomplete spinal cord injury (ASIA Grade A to ASIA Grade C) after one year of staged rehabilitation, the Xuanwu Hospital Capital Medical University team disclosed on 22 May 2026.Sun, 24 May 2026 00:00:00 GMTresearchresearchbeinao-1brain-spine-interfacespinal-cord-injuryxuanwu-hospitalcapital-medical-universityepidural-spinal-stimulationneuroprostheticsasia-impairment-scalechina-clinical-bcionward-medical-comparatorNIH BRAIN Initiative publishes 10-year Neuroscience Research Roadmap in Neuron, anchoring next decade of US federal neuroscience around four Innovation Domainshttps://insidebci.com/policy/2026-05-22-nih-brain-initiative-roadmap-four-innovation-domains-neuroai/https://insidebci.com/policy/2026-05-22-nih-brain-initiative-roadmap-four-innovation-domains-neuroai/NIH BRAIN Initiative Director John Ngai and Acting NINDS Director Amy Bany Adams jointly announced the formal publication of the BRAIN Initiative's 10-year Neuroscience Research Roadmap on 15 May 2026, with a Director's Message and a paper in Neuron. The roadmap, finalised in August 2025, organises the next decade of US federally-funded neuroscience around four Innovation Domains: BRAIN Knowledgebase, Precision Molecular Circuit Therapies, Accelerating Human Neuroscience, and BRAIN NeuroAI.Fri, 22 May 2026 00:00:00 GMTpolicypolicynih-brain-initiativeneuroscience-research-roadmapnindsjohn-ngaiamy-bany-adamsneuroaibrain-knowledgebaseprecision-molecular-circuit-therapiesaccelerating-human-neurosciencefederal-research-policyus-bci-policyNeuralink's surgical robot can now reach any region of the human brain, opening Parkinson's, epilepsy and depression as new target indicationshttps://insidebci.com/news/2026-05-22-neuralink-r1-surgical-robot-any-brain-region-parkinsons-epilepsy-depression/https://insidebci.com/news/2026-05-22-neuralink-r1-surgical-robot-any-brain-region-parkinsons-epilepsy-depression/Neuralink disclosed on 7 May 2026 that its next-generation R1 surgical robot can place electrode threads into virtually any region of the human brain, threading through the dura mater with real-time motion compensation and a suite of eight optical coherence tomography cameras. The scope expansion opens Parkinson's disease, refractory epilepsy, and treatment-resistant depression as new target indications beyond motor-function restoration.Fri, 22 May 2026 00:00:00 GMTnewsnewsneuralinkr1-surgical-robotparkinsonsrefractory-epilepsytreatment-resistant-depressiondura-materoptical-coherence-tomographysubcortical-bciaudrey-crewsmusk-industrial-scaleSwiss BCI startup Neurosoft closes $7.5M seed led by Skybound, the first cheque from a new EIF-anchored European deeptech fundhttps://insidebci.com/news/2026-05-22-neurosoft-bioelectronics-skybound-7-5-million-seed/https://insidebci.com/news/2026-05-22-neurosoft-bioelectronics-skybound-7-5-million-seed/Neurosoft Bioelectronics closed a $7.5 million oversubscribed seed round on 20 May 2026, led by Skybound Venture Capital and joined by PL Capital, IAG Capital Partners, and Connecticut Innovations. The round brings Neurosoft's total funding past $20 million and is the inaugural investment from Skybound, a new Athens-based deeptech fund publicly launched the same week with a $38 million first close anchored by the European Investment Fund.Fri, 22 May 2026 00:00:00 GMTnewsnewsneurosoft-bioelectronicsskybound-venture-capitaleuropean-investment-fundsoft-electrodesstretchable-electrodesbci-seed-fundinglausanneuthealth-houstonumc-utrechtepilepsy-surgery-guidancethaleia-misailidougeorge-varvarelisMedtronic to acquire SPR Therapeutics for $650 million as top-three neuromodulation incumbents consolidate the peripheral nerve stim categoryhttps://insidebci.com/market/2026-05-21-medtronic-spr-therapeutics-650-million-acquisition-pns-consolidation/https://insidebci.com/market/2026-05-21-medtronic-spr-therapeutics-650-million-acquisition-pns-consolidation/Medtronic announced on 20 May 2026 its intent to acquire SPR Therapeutics, the maker of the Sprint percutaneous peripheral nerve stimulation system, for approximately $650 million in upfront cash. The deal is the second top-three neuromodulation acquisition of a PNS specialist in seven months, after Boston Scientific completed its $533 million purchase of Nalu Medical in January 2026.Thu, 21 May 2026 00:00:00 GMTmarketmarketmedtronicspr-therapeuticssprint-pnsperipheral-nerve-stimulationchronic-painm-and-abioelectronic-medicineboston-scientific-naluneuromodulation-consolidationVermont signs H.814 into law, becoming the fifth US state with a neural rights statutehttps://insidebci.com/policy/2026-05-21-vermont-h814-signed-fifth-state-neural-rights/https://insidebci.com/policy/2026-05-21-vermont-h814-signed-fifth-state-neural-rights/Governor Phil Scott signed H.814 into law on 18 May 2026, making Vermont the fifth US state with neural data privacy legislation on the books after Colorado, California, Montana, and Connecticut. The enacted text is the 6-page version of a bill that originally cleared the House at 32 pages; the consent requirement and private right of action did not survive the Senate amendment process. Effective 1 July 2026.Thu, 21 May 2026 00:00:00 GMTpolicypolicyvermonth-814phil-scottneural-rightsneural-data-privacystate-patchworkneurorights-foundationrafael-yustecoloradocaliforniamontanaconnecticutmind-actMobia Medical's $150 million stroke-VNS IPO falls 22% in week one as first major neurotech listing of 2026 underperformshttps://insidebci.com/market/2026-05-20-mobia-medical-150-million-ipo-falls-week-one/https://insidebci.com/market/2026-05-20-mobia-medical-150-million-ipo-falls-week-one/Mobia Medical, the company behind the only FDA-approved implanted vagus nerve stimulator for chronic stroke recovery, priced its $150 million IPO at $15 on 7 May 2026 and closed week one at $11.75. The print resets implied exit math for the pre-IPO bioelectronic-medicine cohort preparing 2026-27 listings.Wed, 20 May 2026 00:00:00 GMTmarketmarketmobia-medicalmicrotranspondervivistimvagus-nerve-stimulationstroke-recoveryipobioelectronic-medicinecapital-marketsnasdaq-mobiBlueWind Medical raises $47.8 million to scale Revi as the implantable tibial neuromodulation category separates from sacral nerve stimulationhttps://insidebci.com/market/2026-05-20-bluewind-medical-revi-47-million-tibial-neuromodulation-oab/https://insidebci.com/market/2026-05-20-bluewind-medical-revi-47-million-tibial-neuromodulation-oab/BlueWind Medical closed $47.8 million in combined equity and debt financing on 14 May 2026 to scale US commercialisation of Revi, the only FDA-cleared implantable tibial neuromodulation device for urgency urinary incontinence. The round follows three-year OASIS pivotal trial data and Medtronic's September 2025 FDA approval of its competing Altaviva tibial system.Wed, 20 May 2026 00:00:00 GMTmarketmarketbluewind-medicalreviimplantable-tibial-neuromodulationoveractive-bladderurgency-urinary-incontinenceoasis-trialbioelectronic-medicinemedtronic-altavivasacral-neuromodulationboston-scientific-axonicsMintNeuro becomes Motif Neurotech's silicon supplier as the BCI supply chain splits from vertical integrationhttps://insidebci.com/market/2026-05-19-mintneuro-motif-silicon-supply-bci-supply-chain-splits/https://insidebci.com/market/2026-05-19-mintneuro-motif-silicon-supply-bci-supply-chain-splits/Imperial College London spinout MintNeuro signed a multi-year commercial supply agreement on 6 May 2026 to provide its miniaturised sensing and stimulation integrated circuits to Motif Neurotech's DOT depression implant across pre-clinical, early clinical, and pivotal trial phases. The deal lands two weeks after Motif's FDA Investigational Device Exemption clearance.Tue, 19 May 2026 00:00:00 GMTmarketmarketmintneuromotif-neurotechdot-implantsupply-chainneural-interface-chipsbci-silicontreatment-resistant-depressionbrain-meshimperial-college-londonrice-universityNeuroPace beats Q1, raises guidance, and posts 77% seizure reduction in expanded-indication trialhttps://insidebci.com/market/2026-05-18-neuropace-q1-2026-nautilus-77-percent-seizure-reduction/https://insidebci.com/market/2026-05-18-neuropace-q1-2026-nautilus-77-percent-seizure-reduction/NeuroPace reported Q1 2026 RNS System revenue of $21.7 million (up 19.5% year-on-year), raised full-year guidance to $99-101 million, and detailed 18-month NAUTILUS trial data showing a 77% median reduction in generalised tonic-clonic seizures. FDA paused the 180-day clock on the expanded-indication review; midyear determination still anticipated.Mon, 18 May 2026 00:00:00 GMTmarketmarketneuropacerns-systemnautilusidiopathic-generalised-epilepsyfda-pmaearningsclosed-loop-neuromodulationwisercmsjoel-beckerRush completes third intracortical visual prosthesis implant as cortical vision restoration becomes a four-platform fieldhttps://insidebci.com/news/2026-05-17-rush-third-icvp-implant-vision-restoration-four-platform-field/https://insidebci.com/news/2026-05-17-rush-third-icvp-implant-vision-restoration-four-platform-field/Illinois Institute of Technology and Rush University Medical Center completed the third implantation of the Intracortical Visual Prosthesis on 7 May 2026, a 34-stimulator, 544-electrode wireless system bypassing the eye and optic nerve to deliver artificial sight directly to the visual cortex.Sun, 17 May 2026 00:00:00 GMTnewsnewsvision-restorationicvpintracortical-visual-prosthesisillinois-institute-of-technologyrush-universityphilip-troykchicago-lighthousecortical-visual-prosthesisneuralink-blindsightrevision-implantscience-corporation-primaHumana becomes first Medicare Advantage payer to cover CVRx Barostim heart-failure therapyhttps://insidebci.com/market/2026-05-16-cvrx-humana-medicare-advantage-barostim-coverage/https://insidebci.com/market/2026-05-16-cvrx-humana-medicare-advantage-barostim-coverage/Humana issues the first Medicare Advantage coverage policy for CVRx's Barostim baroreflex neuromodulation therapy effective 1 May 2026, the fourth 2026 reimbursement and trial milestone for the bioelectronic heart-failure category.Sat, 16 May 2026 00:00:00 GMTmarketmarketbioelectronic-medicinecvrxbarostimhumanamedicare-advantageheart-failurebaroreflex-neuromodulationreimbursementbenefit-hfSynchron co-founder Nicholas Opie joins Control Bionics board as Non-Executive Directorhttps://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/https://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/Opie joins ASX-listed Australian assistive-tech company Control Bionics as Non-Executive Director and strategic advisor, with 1.25 million options vesting over four years pending shareholder approval at the 2026 AGM.Thu, 14 May 2026 00:00:00 GMTmarketmarketexecutive-movementnicholas-opiecontrol-bionicssynchronultra-bionicsaustraliaassistive-technologyboard-appointmentReal-time brain-controlled selective hearing isolates one voice in a crowd in first human studyhttps://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/https://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/Columbia's Zuckerman Institute and collaborators at UCSF, NYU and Northwell Health published the first real-time human-study evidence that an auditory attention decoding BCI can isolate a single speaker in a multi-talker environment.Tue, 12 May 2026 00:00:00 GMTresearchresearchauditory-attention-decodingaadbrain-controlled-hearingcolumbia-zuckerman-institutemesgaraniedward-changconsumer-audiointracranial-eegThailand emerges as a BCI commercial corridor with C.P. Group connecting US and Chinese capabilityhttps://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/https://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/C.P. Group Innovation led Axoft's $55 million Series A on 29 April 2026. One day earlier, C.P. Group subsidiary True Corporation announced a clinical pilot partnership with Shanghai-based OYMotion. The Thai conglomerate is now operating across both Western and Chinese BCI capability through different mechanisms.Sun, 10 May 2026 00:00:00 GMTmarketmarketthailandchina-bcicp-groupcp-group-innovationtrue-corporationoymotionaxoftsoutheast-asiaindustrial-builderneuro-rehabilitationInspire takes the first quantified WISeR hit as Medicare bifurcates its neuromodulation posturehttps://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/https://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.Fri, 08 May 2026 00:00:00 GMTpolicyregulationcmswisermedicareneuromodulationinspire-medicalneuropacereimbursementbci-read-throughOrder 818 takes effect: BCI joins gene and cell therapy on China's parallel commercial trackhttps://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/https://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/The State Council's biomedical-new-technologies regulation took effect 1 May 2026, letting Chinese hospitals charge for BCI commercially after a translation approval. Foreign-invested enterprises remain locked out.Fri, 08 May 2026 00:00:00 GMTpolicyregulationchinaorder-818nmpanhcindustrial-builderneuraclecommercial-pathwayThe sovereign and tech-billionaire rush to access the brain is acceleratinghttps://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/https://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/Oman Investment Authority's Neuralink position is the latest entry in a sovereign-capital and tech-billionaire cohort racing into brain-computer interfaces.Fri, 08 May 2026 00:00:00 GMTopinionopinionsovereign-capitalgeopoliticsbci-investmenttech-giantsneuralinksynchronparadromicsinbrainsynaptrix-labsmerge-labsVermont H.814 clears Senate, neural rights statute awaits Governor Scotthttps://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/https://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/The Senate passed H.814 in concurrence with the House on 6 May. What now sits with Governor Scott is a 6-page recognition statute, with the enforcement layer stripped in committee.Thu, 07 May 2026 00:00:00 GMTpolicyregulationneurorightsvermontus-state-patchworkneural-data-privacyyusteEU AI Act enforcement for BCI medical devices delayed to August 2028 in Council-Parliament dealhttps://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/https://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/The provisional agreement reached on 7 May 2026 pushes high-risk AI obligations by 16 to 24 months, including the rules that capture Class IIb and Class III medical-device BCIs.Thu, 07 May 2026 00:00:00 GMTpolicyregulationeu-ai-acteuropean-unionmedical-devicecompliancehorizontal-regulatordigital-omnibusmdrBioelectronic medicine reaches commercial inflection across four companies in two weekshttps://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/https://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/Spark Biomedical's CEO appointment on May 4 caps a fortnight of substantive bioelectronic-medicine milestones: SetPoint Medical's first multiple sclerosis pilot enrolment on April 30, ResMed's $340 million acquisition of Noctrix Health on the same day, and Nervonik's $52.5 million Series B on April 27. Together the four data points map onto a single maturation arc — growth-stage capital, late-stage trial expansion, commercial scaling, incumbent acquisition — and signal that the category is moving past early-clinical research into the operational layer where all four of those events run in parallel.Tue, 05 May 2026 00:00:00 GMTmarketbioelectronic-medicinespark-biomedicalsetpoint-medicalnervonikresmednoctrixanja-krammervagus-nerveperipheral-nerve-stimcommercial-inflectionm-and-aFormer Harvard chemistry chair Charles Lieber leads state-funded Shenzhen BCI lab i-BRAINhttps://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/https://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/Reuters reported on April 30 that Charles Lieber, the former chair of Harvard's chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft's $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.Thu, 30 Apr 2026 00:00:00 GMTmarketlieberharvardi-brainshenzhenchinasmartmesh-electronicsnanowiretalent-flowchina-initiativestate-fundedfive-year-planUChicago Medicine joins Precision Neuroscience's clinical research network with Layer 7 sensorimotor partnershiphttps://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/https://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/Precision Neuroscience and UChicago Medicine announced on April 30 the launch of a clinical research partnership focused on AI-driven sensorimotor function and neuroprosthetics. The collaboration uses Precision's Layer 7 Cortical Interface, the FDA 510(k)-cleared high-density microelectrode array, and is the second material Precision institutional move of 2026, following the company's January integration with Medtronic's StealthStation surgical navigation system.Thu, 30 Apr 2026 00:00:00 GMTnewsprecision-neurosciencelayer-7uchicago-medicinepeter-warnkesensorimotor-decodingneuroprostheticsmedtronicstealthstationacademic-medical-centreAxoft draws C.P. Group lead in $55M Series A as US BCI company runs first acute implant in Shanghaihttps://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/https://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/Cambridge, Massachusetts implantable BCI company Axoft closed a $55M oversubscribed Series A on April 29, led by Thai conglomerate Charoen Pokphand's strategic arm C.P. Group Innovation with Chinese co-investors Hillhouse and Gaorong, alongside US participants Alumni Ventures and Stanford. The same announcement disclosed Axoft's first acute intraoperative test of its Fleuron polymer probe in a Shanghai patient — the first publicly confirmed clinical use of a US BCI material in China, with more Chinese trials planned this year.Wed, 29 Apr 2026 00:00:00 GMTmarketaxoftfleuronseries-acp-grouphillhousegaorongstanfordalumni-venturesshanghaichinaacute-recordingimplantable-bcipaul-le-flochNeurable launches OEM licensing programme, opening its EEG-decoder stack to consumer hardware makershttps://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/https://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/Neurable announced on April 28 that it has formally opened its consumer-EEG technology to OEM licensing, allowing third-party hardware makers to integrate the company's brain-signal-processing stack into their own products. Named integration partners include HP Inc.'s HyperX, MeSpace, iMotions, and the United States Air Force Research Laboratory. The shift recasts Neurable from a hardware company building its own consumer products into a platform layer for the broader consumer-electronics stack.Tue, 28 Apr 2026 00:00:00 GMTmarketneurableoem-licensingconsumer-bcieeghyperxhpimotionsafrlramses-alcaideneurable-aiplatform-strategyMotif Neurotech's DOT wins FDA IDE for first clinical trial in treatment-resistant depressionhttps://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/https://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/The FDA has approved Motif Neurotech's investigational device exemption to begin a first-in-patient clinical trial of DOT, a millimeter-scale epidurally implanted wirelessly powered brain stimulator that targets the prefrontal cortex. The Rice University spinout, backed by former Neuralink president Max Hodak among others, becomes one of the first companies to attempt an implantable depression therapy at the size and patient-acceptance profile that has eluded every prior DBS-for-depression programme.Mon, 27 Apr 2026 00:00:00 GMTnewsmotif-neurotechdotfdaidedepressiontreatment-resistant-depressionepiduralbrain-stimulatormax-hodakrice-universitymagnetoelectricimplantableOrchestra BioMed and Medtronic move pacemaker-delivered hypertension therapy toward pivotal readouthttps://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/https://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/MODERATO II data presented at Heart Rhythm 2026 shows AVIM Therapy — bioelectronic blood pressure control delivered through a standard dual-chamber pacemaker — produced an 8.1 mmHg net reduction in 24-hour ambulatory systolic BP at six months, with the Medtronic-partnered BACKBEAT pivotal trial now actively enrolling under an FDA-amended protocol.Mon, 27 Apr 2026 00:00:00 GMTnewsorchestra-biomedmedtronicavimbioelectronichypertensionpacemakerhrs-2026fda-breakthroughbackbeatmoderato-iiChina issues guided pricing for invasive BCI procedures as provinces begin reimbursement roll-outhttps://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/https://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/China's National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.Thu, 23 Apr 2026 00:00:00 GMTmarketchinanhsareimbursementpricingneuroxessstairmedneuraclemarket-accessregulatorycmsFDA signals long-horizon regulatory commitment as CorTec joins Total Product Life Cycle Advisory Programhttps://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/https://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/Two weeks after securing Breakthrough Device Designation for stroke rehabilitation, CorTec has been accepted into the FDA's TAP — a dedicated advisory track that pairs the German neurotech company with an agency liaison and early engagement with CMS, signalling an unusually long regulatory horizon for an implanted brain-computer interface.Thu, 23 Apr 2026 00:00:00 GMTnewscortecfdatapbrain-interchangeclosed-loopstrokeregulatorycmsreimbursementMacaque BCI Navigates Virtual Forest With a Single Fixed Decoder Across Task Switcheshttps://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/https://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/A KU Leuven team led by Peter Janssen trained three rhesus macaques to pilot avatars through virtual environments using implanted multi-array BCIs, with premotor cortex outperforming primary motor cortex and a single fixed decoder generalising across perspectives, avatars, and dynamic targets.Wed, 22 Apr 2026 00:00:00 GMTresearchKU-LeuvenJanssenmacaquepremotor-cortexmotor-decodingvirtual-realitybrain-computer-interfaceScience-AdvancesALSParkinsonsMaharbiz Launches Epia Neuro, a Stroke-Focused BCI Built for Lifelong Assistive Usehttps://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/https://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/Michel Maharbiz departed iota Biosciences on 1 April and has emerged with a San Francisco BCI startup targeting post-stroke upper-limb rehabilitation, with a 64-channel epidural array, motorised glove, first-in-human at Lenox Hill later this year, and an FDA submission targeted for February 2027.Wed, 22 Apr 2026 00:00:00 GMTnewsEpia-NeuroMaharbizMandelbaumstrokebrain-computer-interfaceepidural-BCILenox-Hilliota-BiosciencesAstellasNorthwestern Prints Artificial Neurons That Fire Action Potentials Into Live Brain Tissuehttps://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/https://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/A Mark Hersam-led team at Northwestern has demonstrated aerosol-jet-printed neuromorphic devices that generate biologically realistic voltage spikes and trigger responses in mouse cerebellum slices, a first for printed electronics and a potential route to lower-cost, flexible neural interfaces.Wed, 22 Apr 2026 00:00:00 GMTresearchNorthwesternHersamprinted-electronicsneuromorphicMoS2graphenebrain-computer-interfaceneuroprostheticsNature-NanotechnologyINBRAIN Completes Enrolment in World's First-in-Human Graphene Brain-Computer Interface Studyhttps://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/https://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/The Barcelona neurotechnology enrolled ten patients and implanted eight during brain tumour resection at Salford Royal Hospital, completing the first human cohort for any graphene-based neural interface. Full results due later in 2026.Tue, 21 Apr 2026 00:00:00 GMTresearchINBRAIN-Neuroelectronicsgraphene-BCIbrain-computer-interfaceSalford-RoyalUniversity-of-ManchesterKostarelosParkinsons-diseaseBCI-Tx-platformONWARD Medical Raises €40.6m to Scale ARC Therapy Rollout and Fund Implantable Pipelinehttps://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/https://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.Mon, 20 Apr 2026 00:00:00 GMTmarketONWARD-MedicalARC-therapyspinal-cord-injuryEQT-Life-Sciencescapital-raiseEuronextneurotech-commercializationbrain-computer-interfaceANEUVO's spinal stimulator clears the FDAhttps://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/https://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/The ExaStim system — a transcutaneous spinal cord stimulator for people with chronic spinal cord injury — has received FDA 510(k) clearance, making it the first device of its kind cleared for both clinical and home use in the United States.Thu, 16 Apr 2026 00:00:00 GMTnewsANEUVOFDAspinal cord stimulationExaStimspinal cord injuryneuromodulation510(k)Bidirectional brain-computer interface restores sensation during brain-controlled walkinghttps://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/https://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/A UC Irvine-led team has demonstrated the first brain-computer interface that simultaneously controls a walking exoskeleton through decoded brain signals and feeds artificial leg sensation back to the user's sensory cortex — closing the loop on locomotion for the first time.Thu, 16 Apr 2026 00:00:00 GMTresearchUC IrvineCaltechUSCbidirectional BCIexoskeletonsensory feedbackelectrocorticographyBrain StimulationSabi emerges from stealth with a thought-to-text beanie and Khosla backinghttps://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/https://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/California startup Sabi has exited stealth with a non-invasive EEG beanie packing up to 100,000 miniature sensors, a brain foundation model trained on 100,000 hours of neural data, and a plan to ship a consumer thought-to-text device by the end of 2026. Khosla Ventures leads.Thu, 16 Apr 2026 00:00:00 GMTmarketSabiEEGconsumer BCIwearableKhosla Venturesbrain foundation modelthought-to-textNeuroethics 2026 opens at Stanford as the field meets its first commercial momenthttps://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/https://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/The International Neuroethics Society convenes across Stanford, Lucca and Stellenbosch as the BCI sector absorbs $960 million in Q1, a Chinese reimbursement benchmark of US$900 per implant, and 20 Neuralink patients — and the governance window is narrowing.Wed, 15 Apr 2026 00:00:00 GMTpolicyneuroethicsINSStanfordneurorightscognitive libertyneural datagovernanceBCI Pioneers CoalitionPhantom Neuro gets green light for first human trial of its subcutaneous prosthetic sensorhttps://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/https://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/The Melbourne-based startup has received FDA approval to begin a first-in-human study of Phantom X, an implanted sensor array that reads neuromuscular signals from a residual limb without entering the nervous system — aiming to give amputees more natural prosthetic control.Wed, 15 Apr 2026 00:00:00 GMTnewsPhantom NeuroprostheticsCYBORGfirst-in-humansubcutaneous sensoramputationFDAOttobockBlackrock NeurotechChina livestreams a brain implant: Beinao-1 goes livehttps://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/https://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/Hundreds of specialists watched Beijing Tiantan Hospital implant Beinao-1, China's 128-channel semi-invasive brain-computer interface, in a young man paralysed in a scooter accident — part of a clinical ramp that is closing on Neuralink's implant count at roughly 1% of its price.Tue, 14 Apr 2026 00:00:00 GMTnewsBeinao-1ChinaBeijing Tiantan HospitalCIBRNeuCyber NeuroTechsemi-invasive BCIclinical trialsPurdue grows brain electrodes inside the brains of living micehttps://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/https://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/A Purdue team reports in Science that a liquid monomer injected into the motor cortex self-assembles into a conductive electrode mesh — catalysed by the iron in blood — and can then modulate neural activity with external near-infrared light.Tue, 14 Apr 2026 00:00:00 GMTresearchPurdueJianguo Mein-PBDFinjectable electrodesconductive polymersSciencebioelectronicsChina's First BCI Unicorn Pivots Prosthetics Expertise Into Humanoid Robot Handshttps://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/https://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/BrainCo's new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.Mon, 13 Apr 2026 00:00:00 GMTmarketBrainCoroboticsprostheticsdexterous handsChinahumanoid robotsNeural Dust Co-Inventor Headlines Bioelectronic Medicine Forum as Neurotech Investment Accelerateshttps://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/https://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/Michel Maharbiz of iota Biosciences will keynote the ninth annual Bioelectronic Medicine Forum in New York on April 14, with panels on reimbursement and venture capital following a record Q1 for BCI funding.Sat, 11 Apr 2026 00:00:00 GMTmarketbioelectronic-medicine-forummichel-maharbiziota-biosciencesneural-dustventure-capitalneurotech-reportsreimbursementDARPA Launches O-CIRCUIT to Build Living Neural Computers for the Battlefieldhttps://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/https://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/A new 42-month programme will fund teams to build biological processing units from neural organoids, benchmarked against video games and drone navigation, at energy budgets rivalling a fruit fly's brain.Fri, 10 Apr 2026 00:00:00 GMTresearchdarpao-circuitorganoidsbiological-computingbpuedge-aiolfactorychemotaxisdefenceNeuralink Reaches Twenty-Implant Milestone as Surgical Robot Relocates to the UAEhttps://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/https://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/With seven UK patients implanted under the GB-PRIME study and a total of twenty worldwide, Neuralink's R1 surgical robot has moved to Cleveland Clinic Abu Dhabi for the next cohort under the UAE-PRIME trial.Fri, 10 Apr 2026 00:00:00 GMTnewsneuralinkgb-primeuae-primeuclhcleveland-clinicr1-robotn1-implantquadriplegiaColorado Performs Its First Brain-Computer Interface Surgery, Targeting Higher Cognitive Regionshttps://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/https://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/Neurosurgeon Daniel Kramer implants a BCI in a quadriplegic patient at UCHealth University of Colorado Hospital, with electrodes placed in higher-level brain areas rather than motor cortex alone.Thu, 09 Apr 2026 00:00:00 GMTnewscu-anschutzuchealthcoloradoutah-arraycognitive-bcisensory-stimulationdaniel-kramerquadriplegiaCorTec Wins FDA Breakthrough Designation for Stroke Rehab BCI, a First for the Indicationhttps://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/https://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/The German neurotech company becomes the first to receive FDA Breakthrough Device Designation for a brain-computer interface targeting motor recovery after stroke, with its closed-loop Brain Interchange system showing meaningful recovery in a Harborview Medical Center trial.Thu, 09 Apr 2026 00:00:00 GMTnewscortecfdabreakthrough-devicestrokebrain-interchangeclosed-loopharborviewneurostimulationPrecision Neuroscience's Layer 7 Decodes Speech and Movement in First Peer-Reviewed Intraoperative Studyhttps://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/https://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/A Johns Hopkins team reports 77.5% speech classification and 78–84% motor decoding accuracy using Precision's 1,024-channel thin-film cortical array during awake brain surgery in four patients.Wed, 08 Apr 2026 00:00:00 GMTresearchprecision-neurosciencelayer-7electrocorticographyspeech-decodingmotor-decodingjohns-hopkinsmedtronicGAO Names Neural Implants Among Three Emerging Priorities for Congresshttps://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/https://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/A Government Accountability Office report warns that the FDA has no framework for augmentation uses of brain-computer interfaces, even as military and commercial applications advance.Mon, 06 Apr 2026 00:00:00 GMTpolicygaofdapolicyaugmentationregulationLiving Rat Neurons Learn to Generate Complex Signals in Real-Time Reservoir Computing Firsthttps://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/https://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/Tohoku University researchers trained cultured rat cortical neurons to produce sine waves, square waves, and chaotic Lorenz attractors using closed-loop FORCE learning, demonstrating that biological neural networks can serve as computational resources.Mon, 06 Apr 2026 00:00:00 GMTresearchreservoir-computingbiocomputingtohoku-universityorganoid-intelligenceneuroprostheticspnasSynchron's Neural Data Ambitions Earn Fast Company Recognition as BCI Dataset Growshttps://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/https://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/Synchron ranked eighth on Fast Company's 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.Mon, 06 Apr 2026 00:00:00 GMTmarketsynchronneural-datachiralfoundation-modelfast-companyNeuronoff's Needle-Delivered Electrode Works With Standard Pulse Generators in Chronic Animal Studyhttps://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/https://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/Cleveland-based Neuronoff showed its Injectrode platform can connect to off-the-shelf implantable pulse generators, opening neuromodulation targets beyond the spine.Sun, 05 Apr 2026 00:00:00 GMTmarketneuronoffinjectrodeneuromodulationchronic-painperipheral-nerve-stimulationChina Elevates BCI to Government Work Report as Clinical Programmes Expandhttps://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/https://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/Brain-computer interfaces appeared in China's government work report for the first time during the 2026 'two sessions,' placing the technology alongside quantum computing and 6G as a national strategic priority.Sat, 04 Apr 2026 00:00:00 GMTpolicyChinagovernment work reporttwo sessionsNPCCPPCCBCI policyChongqingclinical trialsneuromodulationstroke rehabilitationParalysed Punk Rocker Turns Blackrock Neurotech Implants Into a Musical Instrumenthttps://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/https://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/Galen Buckwalter, a quadriplegic research psychologist with six Utah arrays in his brain, is using a Caltech-developed interface to generate music directly from neural signals.Sat, 04 Apr 2026 00:00:00 GMTnewsblackrock-neurotechcaltechcreative-expressionutah-arraybrain-computer-interfacePersonalised TMS Reaches the Hippocampus Without Surgery, Iowa Study Showshttps://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/https://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/University of Iowa researchers have demonstrated for the first time that non-invasive transcranial magnetic stimulation can modulate hippocampal activity when the stimulation site is tailored to each patient's brain connectivity.Sat, 04 Apr 2026 00:00:00 GMTresearchTMShippocampusnon-invasiveneuromodulationUniversity of IowaNature Communicationspersonalised medicineAlzheimer'sdepressionfMRIEpia Neuro Launches With Read-Write BCI Platform for Stroke Rehabilitationhttps://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/https://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/The startup, led by iota Biosciences founder Michel Maharbiz, is developing a minimally invasive brain-computer interface that pairs neural decoding with a motorized grip-assist glove to restore movement after stroke.Fri, 03 Apr 2026 00:00:00 GMTnewsEpia NeurostrokerehabilitationBCIMichel Maharbiziota BiosciencesLenox Hill Hospitalclosed-loopUS States Build Patchwork of Neural Data Privacy Laws as BCI Market Accelerateshttps://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/https://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.Fri, 03 Apr 2026 00:00:00 GMTpolicyneural dataprivacylegislationConnecticutCaliforniaColoradoMontananeurorightsUNESCOBCIBCI Sector Closes Record First Quarter With Over $960 Million Raisedhttps://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/https://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.Tue, 31 Mar 2026 00:00:00 GMTmarketfundingBCIinvestmentQ1 2026analysisMerge LabsSynchronScience CorpParadromics Begins Recruiting Patients for Connexus Speech-Restoration Trialhttps://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/https://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.Tue, 31 Mar 2026 00:00:00 GMTnewsParadromicsConnexusConnect-Oneclinical trialspeech restorationFDABCIAsilomar Summit Convenes to Build Governance Toolkit for Neurotechnologyhttps://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/https://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/A four-day invitation-only summit modelled on the landmark 1975 DNA conference brings together neuroethicists, investors, and policymakers to create practical governance tools for the BCI industry.Sun, 29 Mar 2026 00:00:00 GMTpolicypolicyneuroethicsgovernanceAsilomarOECDIEEEUNESCOMerge Labs' $252M Bet on Ultrasound BCI Faces Scientific Scrutinyhttps://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/https://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/Sam Altman's brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.Sat, 28 Mar 2026 00:00:00 GMTmarketMerge LabsBCIfundingOpenAIultrasoundSam AltmananalysisOctane's Neuro Tech Forum Draws J&J, Medtronic, and Blackrock Neurotech to Newport Beachhttps://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/https://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/The second annual forum brought together device makers, investors, and six early-stage startups for two days of panels on BCI, neuromodulation, and digital health.Sat, 28 Mar 2026 00:00:00 GMTmarketneurotechinvestmentBCIBlackrock NeurotechOctanemedtechUK Funds £1 Million Philosophy of Neurotechnology Research Labhttps://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/https://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/Four philosophers at Glasgow and Oxford will lead a new interdisciplinary lab examining the ethical and epistemological implications of brain-computer interfaces.Sat, 28 Mar 2026 00:00:00 GMTpolicypolicyethicsUKneurotechnologyphilosophyUKRIGlasgowOxfordSynchron Returns to Melbourne for First Trial of Next-Generation Stentrodehttps://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/https://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/The FOCUS-AU trial will test Synchron's advanced brain-computer interface in ten MND patients across three Australian hospitals, with surgery beginning in April.Wed, 25 Mar 2026 00:00:00 GMTnewsSynchronStentrodeAustraliaFOCUS-AUMNDALSclinical trialAppleCambridge Innovation Institute Acquires Neurotech Reports After 25 Years of Independent Publishinghttps://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/https://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/CII absorbs the neurotechnology sector's longest-running trade publication into its venture and innovation division, with founder James Cavuoto and team staying on.Tue, 24 Mar 2026 00:00:00 GMTmarketNeurotech ReportsCambridge Innovation Instituteacquisitionneurotech industryJames Cavuotobioelectronic medicineChina's Beinao-1 Reaches Five Patients With Semi-Invasive Brain Chiphttps://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/https://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/Five patients now carry the coin-sized wireless implant that sits on the brain's protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.Tue, 24 Mar 2026 00:00:00 GMTnewsBeinao-1NeuCyberChinasemi-invasiveBCINeuralinkALSNia Therapeutics Wins FDA Breakthrough Designation for AI-Guided Memory Implanthttps://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/https://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/The Pennsylvania company's 60-channel Smart Neurostimulation System is the first device to receive Breakthrough Device Designation for TBI-related memory loss.Tue, 24 Mar 2026 00:00:00 GMTnewsNia TherapeuticsFDAmemoryTBIneurostimulationclosed-loopbreakthrough deviceCleveland Startup Sells $350 Brain Stimulation Headset Without FDA Clearance While Clinical Trials Continuehttps://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/https://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/U: The Mind Company began taking orders for a consumer neuromodulation device on March 18, marketing bold clinical claims that have not appeared in peer-reviewed literature. An FDA submission is planned for 2027.Mon, 23 Mar 2026 00:00:00 GMTmarketconsumer-neurotechbrain-stimulationtRNSFDAwellness-devicesregulationFlow Neuroscience Brings First FDA-Approved At-Home Brain Stimulation for Depression to US Markethttps://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/https://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/The Swedish company's FL-100 headset, cleared via the FDA's most stringent PMA pathway, launches in the US in Q2 2026 after a 174-person Nature Medicine trial. A second device, Neurolief's ProlivRx, was approved weeks later.Mon, 23 Mar 2026 00:00:00 GMTnewsFlow-NeuroscienceFDAdepressiontDCSneuromodulationat-home-therapyNeuroliefSpinal Cord Stimulation Restores Both Movement and Sensation in Complete Paralysis for the First Timehttps://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/https://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/A Brown University-led trial published in Nature Biomedical Engineering demonstrates simultaneous motor and sensory restoration in three people with complete spinal cord injuries using patterned electrical stimulation and machine learning.Mon, 23 Mar 2026 00:00:00 GMTresearchspinal-cord-injuryspinal-stimulationBrown-UniversityNature-Biomedical-Engineeringparalysissensory-restorationmotor-restorationBrain Implants Malfunction at Night, Dutch Study Reveals Critical Gap in Round-the-Clock BCI Usehttps://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/https://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/A UMC Utrecht study found that a brain-computer interface trained on daytime neural signals produced 245 false commands per hour when the patient slept, exposing a fundamental problem for 24/7 assistive devices.Sun, 22 Mar 2026 00:00:00 GMTresearchUMC UtrechtECoGALSsleepsignal driftnightmodeassistive technologyFDA's One-Trial Default Lands Just as BCI Companies Approach Pivotal Studieshttps://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/https://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/The agency's new policy ending the two-trial requirement was written for drugs, but brain implant makers watching Synchron, Neuralink, and Paradromics navigate FDA are asking whether the same logic could eventually ease their path.Sun, 22 Mar 2026 00:00:00 GMTpolicyFDAregulationpivotal trialSynchronNeuralinkParadromicsMakaryPrasadcommercializationCambridge's Brain-Inspired Chip Material Could Cut AI Energy Use by 70%https://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/https://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/A new hafnium oxide memristor from the University of Cambridge mimics biological synapses with a million-fold reduction in switching current, pointing toward more efficient neuromorphic hardware.Sat, 21 Mar 2026 00:00:00 GMTresearchneuromorphicmemristorcambridgeenergy-efficiencyhardwareresearchMedicare Has No Plan for Brain-Computer Interfaceshttps://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/https://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/A Health Affairs analysis argues that CMS needs a dedicated coverage pathway for implantable BCIs before the technology outpaces the reimbursement system that patients depend on.Sat, 21 Mar 2026 00:00:00 GMTpolicymedicareCMSpolicyreimbursementhealth-affairspatient-accessFDABeijing's Top BCI Startup Admits It's Three Years Behind Neuralinkhttps://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/https://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/NeuCyber Neurotech's rotating CEO concedes a significant technology gap with Musk's outfit, even as China pours state funding into catching up and expanding human trials to 50 patients.Sat, 21 Mar 2026 00:00:00 GMTnewsneucyberneuralinkchinabci-trialsbeinaogeopoliticsSouth Korea Launches National BCI Strategy With Seven Moonshot Missionshttps://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/https://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/The Ministry of Science and ICT has designated brain-computer interfaces as a core future industry, setting seven mission areas from paralysis treatment to defence applications, with full-scale project funding beginning in 2027.Wed, 18 Mar 2026 00:00:00 GMTpolicySouth KoreaK-Moonshotpolicynational strategyYbraindefenceParadromics Enlists Stanford, Mass General and Pitt to Expand BCI Applicationshttps://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/https://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/The Austin-based neurotech company launches its APEX Partnership Program with five leading research institutions, aiming to push its Connexus brain-computer interface beyond speech restoration into stroke recovery, Parkinson's and motor rehabilitation.Tue, 17 Mar 2026 00:00:00 GMTnewsParadromicsConnexusAPEXStanfordacademic partnershipsspeech restorationBrainGate BCI Restores Typing at 22 Words Per Minute for Paralysed Patientshttps://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/https://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/A brain-computer interface developed by Mass General Brigham and Brown University enabled two paralysed individuals to type at speeds rivalling able-bodied texting, with a word error rate of just 1.6 per cent.Mon, 16 Mar 2026 00:00:00 GMTresearchBrainGatetypingALSspinal cord injuryNature NeuroscienceBelgian Startup ReVision Implant Wins FDA Breakthrough Status for Visual BCIhttps://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/https://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/The Leuven-based neurotech company's Occular system, which uses thousands of micro-electrodes implanted in the visual cortex to restore functional sight, has received FDA Breakthrough Device Designation.Mon, 16 Mar 2026 00:00:00 GMTnewsReVision ImplantFDAvisual prosthesisOccularbreakthrough deviceInside China's Sprint to Own the Brain-Computer Interface Industryhttps://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/https://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/In just nine months China has issued a national BCI blueprint, overtaken the United States in BCI patent filings, funnelled hundreds of millions into startups, and has just granted the world's first commercial implant approval.Sat, 14 Mar 2026 00:00:00 GMTopinionchinaeditorialneuraclestairmedgestalaneuroxessneuralinkindustrial-policyregulationAlibaba Leads $72 Million Round in StairMed as Chinese Tech Giants Enter BCIhttps://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/https://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/The invasive-BCI startup has now raised over $160 million in a year, with Alibaba and Tencent both on the cap table and multicenter clinical trials planned for later this year.Fri, 13 Mar 2026 00:00:00 GMTmarketstairmedalibabatencentchinafundinginvasive-bciChina Grants First Commercial Approval for an Implantable Brain-Computer Interfacehttps://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/https://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/Neuracle Medical Technology secures NMPA clearance, making its coin-sized cortical implant the first invasive BCI anywhere in the world authorised for routine clinical sale.Fri, 13 Mar 2026 00:00:00 GMTnewsneuraclechinanmparegulatoryimplantable-bcicommercialisationGestala Raises $21 Million for Ultrasound BCI in Record Chinese Early-Stage Roundhttps://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/https://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.Thu, 12 Mar 2026 00:00:00 GMTmarketGestalaultrasound BCIChinafundingnon-invasivechronic painTianqiao ChenPhoenix PengSynaptrix Labs Unveils Atlas: Non-Invasive BCI Driving a Wheelchair with Thought Alonehttps://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/https://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/The Mark Cuban-backed startup releases a behind-the-scenes demo of Atlas, a non-invasive brain-computer interface that translates scalp-measured neural activity into real-time wheelchair navigation using deep learning and large-scale neural datasets.Thu, 12 Mar 2026 00:00:00 GMTnewsSynaptrix LabsAtlasnon-invasive BCIEEGwheelchairdeep learningMark Cubanassistive technologyBrain Oscillations Don't Work How We Thought They Didhttps://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/https://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/New research upends a foundational assumption in neuroscience and BCI design: that individual frequency bands reliably map to neural activity. The discovery could reshape how we decode brain signals.Wed, 11 Mar 2026 00:00:00 GMTresearchneural oscillationsbrain decodingprefrontal cortexBCI learningneural ensemblesInvisible Flickers Could Make Brain Monitoring Disappear Into Everyday Interfaceshttps://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/https://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/Researchers developed a near-invisible BCI technique using texture-based visual stimuli to monitor mental workload in pilots without the distraction of traditional flickering screens.Wed, 11 Mar 2026 00:00:00 GMTresearchc-VEPpassive BCImental workloadaviationvisual stimuliDayOne and Cortical Labs to Build Singapore's First Biological Data Centrehttps://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/https://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/The $20 billion data centre operator partners with the Melbourne startup that taught neurons to play Doom, planning to deploy up to 1,000 biological compute units powered by living human brain cells.Tue, 10 Mar 2026 00:00:00 GMTnewsCortical LabsDayOneSingaporebiological computingwetwareNUS Medicinedata centresNeuralink and Rivals Push Brain Chips Toward Commercial Realityhttps://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/https://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/Multiple companies, including Elon Musk's Neuralink, are racing to bring brain-computer interface technology out of research labs and into commercial markets.Tue, 10 Mar 2026 00:00:00 GMTnewsNeuralinkcommercializationbrain chipsneural implantsmarket expansionSelf-Healing Hydrogel Makes Neuromorphic Prosthetics Resilient to Body's Chaoshttps://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/https://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/A new iontronic reservoir built from self-healing hydrogel creates neuromorphic prostheses that can withstand the unpredictable physiological environment inside the human body.Tue, 10 Mar 2026 00:00:00 GMTresearchneuromorphic computinghydrogelneuroprostheticsbiocompatibilityphysical reservoir computingA Paralyzed Man in Munich Controls Computers With His Thoughtshttps://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/https://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/Michael, a quadriplegic patient, uses 256 microelectrodes implanted in his brain to regain autonomy through thought-controlled computing. Researchers in Munich demonstrate how BCIs are moving from experimental to practical.Mon, 09 Mar 2026 00:00:00 GMTnewsinvasive BCIparalysismicroelectrodesclinical applicationsGermanyMIT's AlterEgo Demonstrates Silent Speech Interface in New Demohttps://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/https://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/AlterEgo, spun out from MIT Media Lab, showcases wearable device that translates internal speech into digital commands without vocalization.Mon, 09 Mar 2026 00:00:00 GMTnewssilent speechMIT Media Labwearable BCIAlterEgoneural interfaceNew Database Maps Global Neuroimaging Data for Vision Decodinghttps://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/https://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/A researcher has compiled an index of datasets used to reconstruct what people see from brain activity, potentially accelerating development of visual BCIs and neuroprosthetics.Sun, 08 Mar 2026 00:00:00 GMTresearchvisual perceptionneuroimagingdatasetsmachine learningneural decodingNeuroXess Breaks Ground on China's First BCI 'Super Factory'https://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/https://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/The Chinese neural interface company begins construction of the country's first dedicated manufacturing facility for implantable brain-computer interfaces in Nanchang, signaling a shift from lab to production line.Sun, 08 Mar 2026 00:00:00 GMTnewsNeuroXessChinamanufacturingJiangxiimplantable BCICognito Therapeutics Raises $105M to Bring Alzheimer's Brain Stimulation to Markethttps://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/https://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer's trial nears readout.Sat, 07 Mar 2026 00:00:00 GMTmarketcognito-therapeuticsalzheimersneuromodulationseries-cspectrisEvoked Potentials Could Personalize Stroke Rehab Through BCI Integrationhttps://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/https://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/A comprehensive review maps how brain signals measured during stroke recovery are converging with BCI systems and closed-loop neuromodulation to move rehabilitation beyond generic protocols toward individualized treatment.Sat, 07 Mar 2026 00:00:00 GMTresearchstroke rehabilitationevoked potentialsclosed-loop neuromodulationclinical BCIbiomarkersThe FDA Just Quietly Redrew the Line Between Wellness Device and Medical Devicehttps://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/https://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/New guidance expands the 'general wellness' exemption for wearables and loosens oversight of AI clinical decision tools — with major implications for every company building consumer neurotechnology.Sat, 07 Mar 2026 00:00:00 GMTpolicyfdaregulationwellness-devicesneurotech-regulationclinical-decision-supportwearablesIndia Bets on Brain-Computer Interfaces with IISc Moonshot and Policy Pushhttps://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/https://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/As China and the US race ahead in neurotechnology, India's premier research institute launches an AI brain co-processor project while analysts urge strategic preparation.Sat, 07 Mar 2026 00:00:00 GMTpolicyindiaiiscneurotechnologypolicyglobal-bci-raceInside Neuralink's First Year: Thread Failures, Software Fixes, and Lives Changedhttps://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/https://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/With 12+ patients implanted and mass production planned for 2026, Neuralink's clinical reality is more complicated and more human than the headlines suggest.Sat, 07 Mar 2026 00:00:00 GMTnewsneuralinkclinical-trialsbrain-implantpatient-outcomesmass-productionSalma Health Raises $80M to Build the Operating System for Brain Carehttps://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/https://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/Backed by Mubadala and ARCH Venture Partners, the startup is merging AI diagnostics with FDA-cleared neuromodulation to consolidate fragmented psychiatric and neurological care.Sat, 07 Mar 2026 00:00:00 GMTmarketsalma-healthseries-aneuromodulationtmssaintbrain-healthDual-Pathway Model Reconstructs Speech from Brain Signals in 20 Minuteshttps://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/https://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/New framework resolves the historic trade-off between acoustic richness and linguistic clarity in neural speech decoding, achieving 4.0/5.0 intelligibility with minimal training data.Fri, 06 Mar 2026 00:00:00 GMTresearchspeech BCIECoGneural decodingspeech synthesismachine learningScience Corp Raises $230 Million to Commercialise PRIMA Retinal Implanthttps://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/https://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.Fri, 06 Mar 2026 00:00:00 GMTmarketScience CorpfundingSeries CPRIMAvision restorationretinal implantKhosla VenturesLightspeedTether Backs Eight Sleep at $1.5B Valuation, Deepening Its Health-Tech Thesishttps://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/https://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.Fri, 06 Mar 2026 00:00:00 GMTnewsTetherEight SleepBlackrock Neurotechhealth techinvestmentQVACBlind Korean YouTuber Volunteers for Neuralink's Blindsight Trialhttps://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/https://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink's Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.Thu, 05 Mar 2026 00:00:00 GMTnewsNeuralinkBlindsightclinical trialvision restorationbrain implantSouth KoreaChina Designates BCIs a Strategic Industry with 2027 Breakthrough Targetshttps://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/https://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/Seven Chinese government bodies have released guidelines establishing a roadmap for brain-computer interface development, with BCI procedures now receiving medical insurance reimbursement in parts of the country.Thu, 05 Mar 2026 00:00:00 GMTpolicyChinaBCI policyregulationmedical insuranceglobal marketinvestmentChinese Team Decodes Semantic Meaning From Brain Waves in Aphasia Patientshttps://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/https://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/Researchers developed TFSANet, a deep learning model that decodes language comprehension from EEG signals, achieving 60.73% accuracy in aphasia patients using Chinese linguistic stimuli.Thu, 05 Mar 2026 00:00:00 GMTresearchsemantic decodingaphasiaEEGspeech BCIlanguage processingGobi Partners Backs Cortical Labs as Biological Computing Hub Expands in Malaysiahttps://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/https://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/Malaysia-based Gobi Partners has invested in Cortical Labs through its Dana Impak Ventures fund, joining Horizon Ventures and Synchron founder Tom Oxley in backing the biological computing startup.Thu, 05 Mar 2026 00:00:00 GMTmarketCortical LabsGobi Partnersbiological computingMalaysiainvestmentHorizon VenturesSynchronScience Corp and Neurosoft Partner to Cut BCI Clinical Trial Costshttps://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/https://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/A new partnership between Science Corp and Neurosoft AI aims to dramatically reduce the cost and timeline of brain-computer interface clinical trials through shared infrastructure and software tools.Thu, 05 Mar 2026 00:00:00 GMTnewsScience CorpNeurosoftclinical trialspartnershipsBCI infrastructureSeven-Tesla Brain Scans Reveal Optimal Target for Gesture-Decoding Implantshttps://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/https://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/New fMRI research identifies precise cortical locations for implantable BCI electrodes, finding that surface recordings from gyral regions may suffice for gesture decoding without penetrating sulcal depths.Thu, 05 Mar 2026 00:00:00 GMTresearchimplantable BCImotor cortex mappinggesture decodingelectrode placementfMRISoftware Testing Technique Exposes Safety Flaws in ML Neurostimulationhttps://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/https://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/Researchers adapted automated fuzzing from software security to stress-test machine learning models that control neural implants, revealing widespread violations of biophysical safety limits in retinal and cortical devices.Thu, 05 Mar 2026 00:00:00 GMTresearchmachine learningneural stimulationsafetyvisual prosthesesregulatoryIndian Child Regains Hearing Through Brainstem Neural Implanthttps://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/https://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/AIIMS Delhi performs first auditory brainstem implant in India, demonstrating neural bypass technology's potential for patients unsuitable for conventional cochlear devices.Wed, 04 Mar 2026 00:00:00 GMTnewsauditory brainstem implantAIIMSneural bypasshearing restorationIndiaChinese Startup Gestala Enters Ultrasound BCI Race for Pain Treatmenthttps://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/https://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.Tue, 03 Mar 2026 00:00:00 GMTnewsultrasoundnon-invasive BCIChinachronic painGestalaWireless Retinal Implant Restores Vision in 80% of Trial Participantshttps://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/https://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/A major clinical trial shows wireless neural implants restored meaningful central vision to those blinded by macular degeneration, with participants reading letters and words.Tue, 03 Mar 2026 00:00:00 GMTnewsretinal implantsvisual prostheticsclinical trialsmacular degenerationsensory restorationBrain Stimulation Improves BCI Control Through Two Distinct Neural Pathwayshttps://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/https://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/New research reveals how targeting different brain regions with theta burst stimulation enhances motor imagery performance through separate mechanisms, offering potential solutions for stroke patients struggling with BCI control.Mon, 02 Mar 2026 00:00:00 GMTresearchtranscranial magnetic stimulationmotor imagerystroke rehabilitationbrain stimulationfunctional connectivityLiving Neurons Learn Doom in a Week, Signaling New Erahttps://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/https://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.Sun, 01 Mar 2026 00:00:00 GMTnewsorganoid intelligencebiological computingCortical Labsin vitro neuronssynthetic biologyNeuroXess Completes Human Trials as China Accelerates BCI Racehttps://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/https://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.Sun, 01 Mar 2026 00:00:00 GMTnewsNeuroXessChinaNeuralinkhuman trialsinternational competitionNicolelis Study in China Shows Brain Reorganization Restores Movementhttps://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/https://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.Sun, 01 Mar 2026 00:00:00 GMTnewsMiguel Nicolelisparalysisneural plasticityChinamotor recoveryPersonalized Brain Decoders Track Chronic Pain Without Patient Inputhttps://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/https://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.Sun, 01 Mar 2026 00:00:00 GMTresearchpain decodingfMRIchronic painpersonalized medicineneuroimagingNeuralink Clears Major Hurdle: FDA Approves Expanded Clinical Trial Enrollmenthttps://insidebci.com/news/neuralink-fda-expanded-trial/https://insidebci.com/news/neuralink-fda-expanded-trial/FDA grants approval for Neuralink to enroll significantly more participants in its brain-computer interface clinical trials, marking a major step toward commercialization.Sat, 28 Feb 2026 00:00:00 GMTnewsneuralinkFDAclinical-trialsbrain-computer-interfaceEU Proposes Landmark 'Neuro-Rights' Framework: First Major Regulatory Push for Brain Data Privacyhttps://insidebci.com/policy/eu-neuro-rights-framework/https://insidebci.com/policy/eu-neuro-rights-framework/European Commission outlines sweeping rules protecting cognitive liberty and neural data, setting global standard for brain-computer interface regulation.Sun, 22 Feb 2026 00:00:00 GMTpolicyEU-regulationneuro-rightsprivacypolicy